Depression medications

ANTIDEPRESSANTS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints MRI_NONSEL SSRI MAOI_NONSEL MAOI_A OTHER_ANTIDEPRESSANTS	162869
6. Filter based on genotype QC (FinnGen only)	157103

Control definitions (FinnGen only)

Control exclude: NEURO_COMORBIDITIES

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ANTIDEPRESSANTS
CONTROL_EXCLUDE	NEURO_COMORBIDITIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	MRI_NONSEL\|SSRI\|MAOI_NONSEL\|MAOI_A\|OTHER_ANTIDEPRESSANTS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Depression medications based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1301037	797631	495459
Only index persons	1186033	738521	447512
Unadjusted period prevalence (%)
Whole population	19.33	22.85	13.84
Only index persons	23.35	27.15	17.08
Median age at first event (years)
Whole population	45.17	45.51	44.51
Only index persons	43.34	43.69	42.76

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	157103	103104	53999
Unadjusted period prevalence (%)	32.51	36.57	24.74
Median age at first event (years)	44.87	42.55	49.30

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
21363: Matched controls
107399

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

58.4

323.3

332

C10AA07

ATC

rosuvastatin; oral

2.3

323.3

3456

8414

PHD99

NOMESCO Finland

Resection of other vein

2085.4

320.3

412

T82

ICPC

Obesity

5.7

319.6

826

757

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

71.2

319.1

321

N06BA12

ATC

lisdexamfetamine; oral

21.6

319.0

396

N06AA04

ATC

clomipramine; systemic

44.3

317.3

338

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.2

316.8

1619

2649

M03BC01

ATC

orphenadrine (citrate); systemic

2.1

316.7

4363

11783

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

+∞

316.6

404

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.8

316.5

2156

4200

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.5

316.3

1028

1185

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

316.0

4950

14031

SPAT1254

SPAT

Administration of medicine

2.6

315.0

2465

5171

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.8

315.0

791

702

C08CA13

ATC

lercanidipine; oral

4.4

314.3

1057

1256

ZXE00

NOMESCO Finland

One hour or less

1.9

312.4

6434

20042

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

64.3

309.9

315

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.2

307.8

1593

2627

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

14.4

307.7

955

349

N05BA01

ATC

diazepam; systemic, rectal

8.6

307.7

2906

1935

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

7.3

307.7

1057

758

Z71.8

ICD-10 Finland

Other specified counselling

2.2

307.7

6503

17640

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

540.0

307.7

626

E66.01

ICD-10 Finland

Obesity due to excess calories

4.3

307.7

1901

2366

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

547.1

307.7

634

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

307.7

706

AA1AD

NOMESCO Finland

CT of head and brain

4.4

307.7

3516

4607

F41.00

ICD-10 Finland

Moderate panic disorder

128.4

307.7

596

Z3231

NOMESCO Finland

Registered nurse

3.3

307.7

4809

8604

SPAT1234

SPAT

Support of social functional capacity

11.5

307.7

684

309

N06AA06

ATC

trimipramine; systemic

27.7

307.7

464

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

307.7

15148

58862

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.5

307.7

5025

11653

N05BA04

ATC

oxazepam; oral

13.9

307.7

7690

4176

F60.9

ICD-10 Finland

Personality disorder, unspecified

83.6

307.7

424

C07AB07

ATC

bisoprolol; oral

6.6

307.7

5874

5825

I10

ICD-10 Finland

Essential (primary) hypertension

3.2

307.7

6262

12360

N05CD07

ATC

temazepam; oral

16.3

307.7

1591

526

N05BA06

ATC

lorazepam; systemic, sublingual

40.8

307.7

902

116

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.6

307.7

4185

6778

ZXE20

NOMESCO Finland

More than three and less than five hours

4.1

307.7

1601

2105

IBA03

NOMESCO Finland

Psychotherapy evaluation

79.1

307.7

356

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

307.7

3065

6710

D64.9

ICD-10 Finland

Anaemia, unspecified

9.1

307.7

773

441

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.2

307.7

1235

1262

P01

ICPC

Feeling anxious/nervous/tense

5.9

307.7

5379

5760

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

14.4

307.7

467

167

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

5.2

307.7

1278

1297

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

57.6

307.7

1272

118

SPAT1262

SPAT

Handing over of treatment supplies

7.4

307.7

2002

1484

A02BC02

ATC

pantoprazole; systemic

3.0

307.7

12303

33451

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

307.7

3078

6944

Z2445

NOMESCO Finland

Psychologist

16.1

307.7

1318

438

I47.1

ICD-10 Finland

Supraventricular tachycardia

21.9

307.7

403

P99

ICPC

Psychological disorders other

22.2

307.7

1037

246

IGY99

NOMESCO Finland

Other psychiatric treatment contact

83.1

307.7

827

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

49.8

307.7

1242

133

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

152.7

307.7

417

R02

ICPC

Shortness of breath/dyspnoea

3.2

307.7

1878

3173

P06

ICPC

Sleep disturbance

4.4

307.7

3043

3931

M79.7

ICD-10 Finland

Fibromyalgia

10.2

307.7

736

373

N02BE01

ATC

paracetamol; systemic, rectal

2.7

307.7

17399

66923

SPAT1260

SPAT

Consultation of another employee

2.5

307.7

2889

6420

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

151.3

307.7

1869

A04

ICPC

Weakness/tiredness general

3.0

307.7

2991

5525

M54.5

ICD-10 Finland

Low back pain

2.1

307.7

7220

20757

F51.0

ICD-10 Finland

Nonorganic insomnia

4.8

307.7

4925

6310

R51.80

ICD-10 Finland

Headache

2.9

307.7

3652

7074

F32.0

ICD-10 Finland

Mild depressive episode

7.4

307.7

772

544

N07BB01

ATC

disulfiram; oral

16.4

307.7

1346

438

A10BJ06

ATC

semaglutide; parenteral

+∞

307.7

606

N06AB05

ATC

paroxetine; oral

39.4

307.7

1886

263

E11

ICD-10 Finland

Type 2 diabetes mellitus

26.3

307.7

1522

312

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

26.3

307.7

436

JN4BD

NOMESCO Finland

Extensive body CT

7.3

307.7

817

579

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

307.7

495

N06AB04

ATC

citalopram; systemic

40.9

307.7

6836

1223

B01AF02

ATC

apixaban; oral

20.9

307.7

625

155

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

159.2

307.7

2903

106

ZXE10

NOMESCO Finland

More than one and less than three hours

2.4

307.7

5280

12822

F34.1

ICD-10 Finland

Dysthymia

82.5

307.7

1296

F41.1

ICD-10 Finland

Generalized anxiety disorder

20.0

307.7

2337

654

C07AB02

ATC

metoprolol; systemic

5.5

307.7

1725

1680

N06BA04

ATC

methylphenidate; oral

13.4

307.7

1538

617

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

6.5

307.7

2651

2301

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

191.6

307.7

1188

N02BF01

ATC

gabapentin; oral

4.9

307.7

1431

1536

A10BK01

ATC

dapagliflozin; oral

227.5

307.7

658

N05AX08

ATC

risperidone; systemic

45.9

307.7

2089

253

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

346.8

307.7

604

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

51.4

307.7

1645

174

A10AE04

ATC

insulin glargine; parenteral

87.4

307.7

1074

N05AN01

ATC

lithium; oral

226.3

307.7

739

A02BC03

ATC

lansoprazole; oral

2.4

307.7

3943

9258

A10AB05

ATC

insulin aspart; parenteral

116.2

307.7

908

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

10.6

307.7

1361

686

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

1458

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

102.8

307.7

845

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.6

307.7

1072

1004

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

109.8

307.7

407

UJF32

NOMESCO Finland

Coloscopy

2.8

307.7

3100

6211

E03

ICD-10 Finland

Other hypothyroidism

39.1

307.7

693

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

147.4

307.7

953

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

307.7

8411

28060

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

8.8

307.7

692

406

R07.4

ICD-10 Finland

Chest pain, unspecified

3.2

307.7

3956

7073

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

307.7

5784

16698

F40.1

ICD-10 Finland

Social phobias

33.6

307.7

1229

195

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.5

307.7

3024

6680

C01DA14

ATC

isosorbide mononitrate; oral

35.1

307.7

571

P01AB01

ATC

metronidazole; oral, rectal

1.9

307.7

6919

21777

N06AG02

ATC

moclobemide; oral

53.7

307.7

921

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.7

307.7

781

601

N05CF02

ATC

zolpidem; oral

5.7

307.7

4251

4481

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

11075

36758

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

307.7

7869

24073

F10.25

ICD-10 Finland

Alcohol dependence continuous use

23.8

307.7

422

I48

ICD-10 Finland

Atrial fibrillation and flutter

86.2

307.7

951

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.1

307.7

2017

3522

N03AX12

ATC

[U] gabapentin; oral

5.1

307.7

3068

3396

A06AC01

ATC

ispaghula (psylla seeds); oral

2.8

307.7

3741

7491

L28

ICPC

Limited function/disability (L)

3.4

307.7

1829

2849

I25.1

ICD-10 Finland

Atherosclerotic heart disease

84.2

307.7

1082

N05AH04

ATC

quetiapine; oral

34.1

307.7

7554

1698

A28

ICPC

Limited function/disability NOS

5.2

307.7

1320

1331

C09AA05

ATC

ramipril; oral

5.6

307.7

1935

1888

A04AA02

ATC

granisetron; systemic, transdermal

68.9

307.7

456

C10AA01

ATC

simvastatin; oral

3.2

307.7

3146

5523

N05AH02

ATC

clozapine; systemic

1030.7

307.7

613

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.7

307.7

3332

6972

N05AD01

ATC

haloperidol; systemic

36.1

307.7

485

F41.8

ICD-10 Finland

Other specified anxiety disorders

8.5

307.7

1129

703

A01

ICPC

Pain general/multiple sites

3.9

307.7

1482

2015

S18

ICPC

Laceration/cut

2.0

307.7

7041

20907

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

10.7

307.7

1505

756

A10AE05

ATC

insulin detemir; parenteral

372.9

307.7

578

103

Kela drug reimbursment

Diabetes, insulin-treated

5530.6

307.7

2877

F39

ICD-10 Finland

Unspecified mood [affective] disorder

35.7

307.7

627

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2189.9

307.7

432

XA800

NOMESCO Finland

Neuropsychological investigation

6.7

307.7

741

577

A02BC05

ATC

esomeprazole; systemic

2.3

307.7

6735

18187

SPAT1301

SPAT

No procedures

2.0

307.7

5261

14887

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

252.2

307.7

727

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

307.7

2394

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

125.6

307.7

536

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

123.4

307.7

735

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

27.6

307.7

1422

277

A06AD11

ATC

lactulose; oral

5.1

307.7

1614

1707

N05AF03

ATC

chlorprothixene; systemic

413.4

307.7

716

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

307.7

2964

6000

F43.1

ICD-10 Finland

Post-traumatic stress disorder

11.8

307.7

956

423

L03

ICPC

Low back symptom/complaint

2.2

307.7

5457

14576

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

66.6

307.7

416

N06AB03

ATC

fluoxetine; oral

44.7

307.7

4193

584

F61.0

ICD-10 Finland

Mixed personality disorders

181.0

307.7

561

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.6

307.7

1121

1275

N05CF01

ATC

zopiclone; oral

7.5

307.7

6738

6193

B01AA03

ATC

warfarin; systemic

26.1

307.7

934

188

ZYC01

NOMESCO Finland

Remote contact by phone

7.5

307.7

1347

954

A02BC01

ATC

omeprazole; systemic

2.4

307.7

4186

9784

OAB93, ,

SPAT

3.6

307.7

1595

2381

A10BH01

ATC

sitagliptin; oral

492.8

307.7

757

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

26.0

307.7

421

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

150.4

307.7

382

N06AB08

ATC

fluvoxamine; oral

55.6

307.7

560

I50.9

ICD-10 Finland

Heart failure, unspecified

145.6

307.7

509

N06AX03

ATC

mianserin; oral

51.6

307.7

981

100

205

Kela drug reimbursment

Chronic hypertension

+∞

307.7

1574

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

85.1

307.7

767

G47.3

ICD-10 Finland

Sleep apnoea

3.6

307.7

4062

6617

Z3226

NOMESCO Finland

Physiotherapist

3.0

307.7

2778

5163

WZC00

NOMESCO Finland

Treatment plan or consultation

2.0

307.7

6567

19133

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

307.7

6377

11371

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.0

307.7

2104

3787

F41.3

ICD-10 Finland

Other mixed anxiety disorders

13.3

307.7

540

209

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

104.2

307.7

721

XF404

NOMESCO Finland

Ambulatory ECG

8.9

307.7

770

447

AN1

Coronary angiography

92.4

307.7

485

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

3.8

307.7

1681

2358

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.6

307.7

1921

2857

N06AX05

ATC

trazodone; oral

88.4

307.7

714

A10BJ02

ATC

liraglutide; parenteral

70.4

307.7

358

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

89.8

307.7

403

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

20.6

307.7

414

103

N06AX22

ATC

agomelatine; oral

120.5

307.7

874

P76

ICPC

Depressive disorder

30.5

307.7

2965

565

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.0

307.7

1450

1914

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

307.7

3676

8478

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

12.0

307.7

542

233

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.7

307.7

1733

1991

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

494.8

307.7

575

215

Kela drug reimbursment

Diabetes, non-insulin-treated

16325.0

307.7

2825

P74

ICPC

Anxiety disorder/anxiety state

15.1

307.7

1806

654

F31

ICD-10 Finland

Bipolar affective disorder

153.2

307.7

389

R06.0

ICD-10 Finland

Dyspnoea

3.4

307.7

3934

6742

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

125.1

307.7

581

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

307.7

2081

3401

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

70.6

307.7

359

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

126.7

307.7

824

T89

ICPC

Diabetes insulin dependent

174.4

307.7

574

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

1171.0

307.7

466

P29

ICPC

Psychological sympt/compl other

7.3

307.7

2717

2104

SPAT1307

SPAT

Psychosocial counselling and guidance

4.6

307.7

2422

2932

F32

ICD-10 Finland

Depressive episode

21.6

307.7

2156

555

SPAT1240

SPAT

Therapeutic discussion

6.7

307.7

4008

3571

F31.8

ICD-10 Finland

Other bipolar affective disorders

197.3

307.7

684

A10AE06

ATC

insulin degludec; parenteral

+∞

307.7

431

M03BX02

ATC

tizanidine; oral

1.9

307.7

12265

44893

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

15.6

307.7

501

165

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

597.7

307.7

911

N05BA02

ATC

chlordiazepoxide; systemic

29.9

307.7

431

104

Kela drug reimbursment

Thyroid insufficiency

949.4

307.7

567

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

7.3

307.7

694

493

H02AB06

ATC

prednisolone; systemic

2.0

307.7

7598

23676

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

8.6

307.7

1709

1081

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

237.0

307.7

2462

R5140

NOMESCO Finland

Monitoring the use of the aid

3.8

307.7

1590

2244

R11

ICD-10 Finland

Nausea and vomiting

3.7

307.7

1591

2306

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

29.7

307.7

653

114

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

7.7

307.7

1188

819

N06AB10

ATC

escitalopram; oral

44.1

307.7

9894

2061

PJA12

NOMESCO Finland

Sentinel node biopsy

20.7

307.7

512

127

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2763.1

307.7

541

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

27.7

307.7

1079

206

N05AA02

ATC

levomepromazine; systemic

126.5

307.7

1053

B01AB05

ATC

enoxaparin; parenteral

2.5

307.7

3531

7895

H03AA01

ATC

levothyroxine sodium; systemic

27.8

307.7

3474

744

P15

ICPC

Chronic alcohol abuse

13.4

307.7

847

329

F32.9

ICD-10 Finland

Depressive episode, unspecified

40.7

307.7

5845

986

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

255.8

307.7

737

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

93.2

307.7

1420

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

7.2

307.7

822

590

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

307.7

3970

9402

N05AB03

ATC

perphenazine; systemic, rectal

117.1

307.7

872

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

628.4

307.7

1933

A02BA02

ATC

ranitidine; systemic

2.8

307.7

2225

4349

WZC30

NOMESCO Finland

Teaching

3.2

307.7

1807

2990

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

116.1

307.7

1033

E03.89

ICD-10 Finland

Other specified hypothyroidism

45.5

307.7

382

115

Kela drug reimbursment

Breast cancer

+∞

307.7

563

Z2221

NOMESCO Finland

Medical doctor

2.2

307.7

4584

12001

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

307.7

7567

20545

E66.00

ICD-10 Finland

Metabolic syndrome

7.5

307.7

761

525

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

12.1

307.7

1880

847

ZY010

NOMESCO Finland

Hospital outpatient

18.6

307.7

1811

531

F41.09

ICD-10 Finland

UNS Panic Syndrome

28.2

307.7

1128

212

N06AX11

ATC

mirtazapine; oral

16.2

307.7

11020

6635

TPH07

NOMESCO Finland

Cathetrisation of artery

5.9

307.7

979

872

L17

ICPC

Foot/toe symptom/complaint

2.2

307.7

4797

12390

N02BF02

ATC

pregabalin; oral

8.4

307.7

1202

760

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

53.2

307.7

2249

237

R4110

NOMESCO Finland

Physiotherapy

2.6

307.7

3940

8540

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

11.9

307.7

1740

797

T86

ICPC

Hypothyroidism/myxoedema

30.7

307.7

454

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

9.4

307.7

858

478

M79.6

ICD-10 Finland

Pain in limb

2.1

307.7

7510

21862

Z2446

NOMESCO Finland

Social worker

10.4

307.7

1571

814

N03AE01

ATC

clonazepam; systemic

12.7

307.7

1243

519

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

12.8

307.7

3793

1777

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

7.0

307.7

1417

1074

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

8.3

307.7

1594

1035

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

28.4

307.7

437

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

559

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

8.6

307.7

2293

1489

N06AX26

ATC

vortioxetine; oral

83.7

307.7

3396

242

N06AX12

ATC

bupropion; oral

59.3

307.7

3634

370

N03AX09

ATC

lamotrigine; oral

30.4

307.7

1895

343

A10AB01

ATC

insulin (human); parenteral

223.7

307.7

436

N06AB06

ATC

sertraline; oral

56.2

307.7

4962

575

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

151.0

307.7

1272

C08CA01

ATC

amlodipine; oral

3.6

307.7

3531

5527

SPAT1243

SPAT

Psychiatric/psychological examination

9.8

307.7

1029

553

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

307.7

8136

24000

C03DA01

ATC

spironolactone; oral

6.3

307.7

927

766

B01AC04

ATC

clopidogrel; oral

15.6

307.7

926

311

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

9.7

307.7

724

388

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

48.8

307.7

344

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

469

F29

ICD-10 Finland

Unspecified nonorganic psychosis

828.9

307.7

1372

F32.1

ICD-10 Finland

Moderate depressive episode

20.9

307.7

2604

709

N06AA09

ATC

amitriptyline; systemic

11.9

307.7

1618

736

N05AX12

ATC

aripiprazole; systemic

468.2

307.7

1870

N02AA05

ATC

oxycodone; systemic

6.5

307.7

1663

1368

R42

ICD-10 Finland

Dizziness and giddiness

2.7

307.7

3186

6444

N03AG01

ATC

valproic acid; systemic, rectal

13.1

307.7

1587

653

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

70.1

307.7

870

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

307.7

7413

23490

F90.0

ICD-10 Finland

Disturbance of activity and attention

13.4

307.7

1726

702

WX892

NOMESCO Finland

Monitored bed care

6.6

307.7

852

672

XF400

NOMESCO Finland

ECG with 12 standard connections

5.0

307.7

1841

1991

F32.8

ICD-10 Finland

Other depressive episodes

27.7

307.7

491

IGY02

NOMESCO Finland

Psychiatric monitoring contact

68.8

307.7

1116

N02AX02

ATC

tramadol; systemic, rectal

2.9

307.7

7131

15834

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

25.5

307.7

1553

329

XF402

NOMESCO Finland

ECG with work load test

6.6

307.7

859

682

F99

ICD-10 Finland

Mental disorder, not otherwise specified

51.7

307.7

639

SPAT1310

SPAT

Counselling related to known health issue

2.1

307.7

5865

16666

C03CA01

ATC

furosemide; systemic

11.2

307.7

2008

982

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

11.1

307.7

4413

2466

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

14.2

307.7

1105

410

G44.2

ICD-10 Finland

Tension-type headache

2.7

307.7

2822

5642

A03FA01

ATC

metoclopramide; systemic, rectal

4.0

307.7

3193

4553

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.4

307.7

1797

2815

P03

ICPC

Feeling depressed

10.3

307.7

4448

2682

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

9.3

307.7

1165

659

ZY000

NOMESCO Finland

Hospital inpatient

129.4

307.7

429

A10BK03

ATC

empagliflozin; oral

476.2

307.7

907

N06AX16

ATC

venlafaxine; oral

110.3

307.7

6204

397

T36

ICD-10 Finland

Poisoning by systemic antibiotics

36.5

307.7

1571

233

F10.24

ICD-10 Finland

Alcohol depence active use

30.4

307.7

415

N04AA02

ATC

biperiden; systemic

57.6

307.7

383

A10AC01

ATC

insulin (human); parenteral

14.1

307.7

810

299

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

731

R53

ICD-10 Finland

Malaise and fatigue

3.1

307.7

4898

9380

N06AX21

ATC

duloxetine; oral

34.7

307.7

3842

674

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

17.0

307.7

557

169

P72

ICPC

Schizophrenia

411.9

307.7

481

E66.8

ICD-10 Finland

Other obesity

6.6

307.7

1160

928

J01DB01

ATC

cefalexin; oral

2.0

307.7

16667

68886

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

86.8

307.7

669

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

661

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

128.6

307.7

836

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.3

307.7

1060

1042

H02AB02

ATC

dexamethasone; systemic

14.2

307.7

908

335

A10AB04

ATC

insulin lispro; parenteral

85.8

307.7

402

N05BA12

ATC

alprazolam; oral

14.9

307.7

2506

947

F10.20

ICD-10 Finland

Alcohol dependence currently independent

28.1

307.7

534

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

10.0

307.7

1540

828

207

Kela drug reimbursment

Chronic arrhythmias

290.8

307.7

618

T90

ICPC

Diabetes non-insulin dependent

29.4

307.7

2469

475

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

741.8

307.7

570

C10AX09

ATC

ezetimibe; oral

5.0

307.7

1345

1413

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

13.4

307.7

4793

2262

A10BA02

ATC

metformin; oral

25.0

307.7

3183

747

C10AA05

ATC

atorvastatin; oral

3.0

307.7

3908

7412

N03AX16

ATC

[U] pregabalin

5.2

307.7

4342

5001

N05BE01

ATC

buspirone; oral

71.0

307.7

802

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

307.7

2831

6211

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

307.7

4310

10045

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

64.7

307.7

3889

368

F33

ICD-10 Finland

Recurrent depressive disorder

60.6

307.7

912

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

368.3

307.7

571

XX3DW

NOMESCO Finland

Time consuming IT work

5.6

307.7

966

907

IHZ05, ,

SPAT

5.2

307.7

1465

1507

N06CA01

ATC

amitriptyline and psycholeptics; systemic

6.6

307.7

1716

1410

JN4AD

NOMESCO Finland

Body CT examination

7.2

307.7

749

539

N06AA12

ATC

doxepin; systemic

28.9

307.7

872

158

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3203.7

307.7

624

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.7

307.7

1413

2007

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

6.7

307.7

771

600

N05AH03

ATC

olanzapine; systemic

242.6

307.7

2362

SPAT1215

SPAT

Assessment of need for medical rehabilitation

6.3

307.7

778

640

WX402

NOMESCO Finland

General anaesthesia

2.4

307.7

3349

7871

C07AA05

ATC

propranolol; systemic

6.1

307.7

5862

6302

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

15.1

307.7

1124

394

C09AA02

ATC

enalapril; systemic

3.6

307.3

1313

1894

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.6

306.9

1360

2015

F33.8

ICD-10 Finland

Other recurrent depressive disorders

116.5

306.4

297

M54.4

ICD-10 Finland

Lumbago with sciatica

2.3

306.1

3124

7436

IGY02, ,

SPAT

32.0

306.1

345

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

4.4

306.0

1023

1209

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

304.2

6174

19107

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

303.7

11186

41479

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

12.9

303.6

455

181

C09CA06

ATC

candesartan; oral

2.3

302.4

3205

7754

WX290

NOMESCO Finland

Other blockage of nerve

1.7

301.9

11231

41738

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

1949.8

299.9

386

WX002

NOMESCO Finland

Sedation and analgesia

2.6

298.3

2370

5003

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

32.8

297.7

334

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

297.7

380

IGV01

NOMESCO Finland

Psychiatric network contact

336.8

297.2

395

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

294.2

5410

16166

SPAT1263

SPAT

Sampling

1.8

293.8

7709

25803

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.6

293.3

1285

1887

SPAT1097

SPAT

Recording of ECG

3.3

293.2

1469

2369

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

65.8

292.9

297

IEY01

NOMESCO Finland

Psychoeducation, individual

142.6

292.0

280

OAA65, ,

SPAT

2.0

289.7

4512

12707

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

19.2

289.4

372

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

289.2

1406

2221

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

28.2

286.7

332

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

109.3

286.7

279

M03BC51

ATC

orphenadrine, combinations; systemic

2.0

286.5

4794

13845

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

7.3

285.6

598

423

F60.5

ICD-10 Finland

Anankastic personality disorder

28.5

284.6

329

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

282.6

15802

65476

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

282.6

3878

10405

L03AA13

ATC

pegfilgrastim; parenteral

46.2

282.4

299

R52.2

ICD-10 Finland

Other chronic pain

6.4

281.5

649

520

A04AA55

ATC

palonosetron, combinations; systemic

56.8

281.4

290

N01

ICPC

Headache

2.2

279.3

3072

7532

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

83.0

279.1

277

J01AA02

ATC

doxycycline; systemic

1.7

278.0

13389

52963

P16

ICPC

Acute alcohol abuse

11.9

277.8

432

186

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

51.0

277.6

290

C09CA01

ATC

losartan; oral

2.5

277.2

2331

5052

N04BC05

ATC

pramipexole; oral

4.4

276.8

928

1098

R4190

NOMESCO Finland

Nutritional therapy

6.6

276.3

625

489

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

13.3

276.3

408

157

IGP01

NOMESCO Finland

Psychiatric family contact

52.2

275.6

287

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.7

275.4

854

941

H04AA01

ATC

glucagon; nasal, parenteral

312.4

275.4

367

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

81.8

274.7

273

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.1

274.0

1465

2462

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

271.3

2954

7205

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

76.4

270.1

270

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

54.4

268.4

278

N06AA10

ATC

nortriptyline; systemic

12.8

268.3

403

161

M01AE02

ATC

naproxen; oral, rectal

1.7

267.6

11406

43415

OAB50, ,

SPAT

7.4

265.6

547

378

M25.5

ICD-10 Finland

Pain in joint

1.8

264.1

5809

18291

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

264.0

9693

35387

I20.99

ICD-10 Finland

Angina pectoris, unspecified

74.6

263.5

264

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.0

263.4

4333

12390

L01

ICPC

Neck symptom/complaint

2.2

261.9

2943

7267

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.1

261.7

3413

8952

SPAT1216

SPAT

Assessment of functional ability

2.9

261.5

1558

2798

D11

ICPC

Diarrhoea

2.3

261.4

2655

6275

WX872

NOMESCO Finland

Intensive care

12.7

261.1

394

159

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.8

260.8

1742

3342

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

18.5

260.1

338

L02BA01

ATC

tamoxifen; oral

24.4

259.3

311

F93.89

ICD-10 Finland

Other childhood emotional disorders

351.1

259.1

344

J01FF01

ATC

clindamycin; systemic

1.9

258.4

4288

12289

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

46.3

258.0

273

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.5

257.5

1157

1727

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

255.4

2269

5040

D01

ICPC

Abdominal pain/cramps general

2.3

254.8

2479

5743

M79.1

ICD-10 Finland

Myalgia

2.2

254.2

2790

6814

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

252.1

322

N03AX11

ATC

topiramate; oral

6.5

252.1

577

458

E66.9

ICD-10 Finland

Obesity, unspecified

5.5

251.3

670

634

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

9.5

250.1

439

237

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

249.2

4894

14818

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

78.8

248.8

248

XCK10

NOMESCO Finland

Photography of fundus of eye

4.3

248.6

849

1020

P19

ICPC

Drug abuse

15.7

247.2

341

111

M79.0

ICD-10 Finland

Rheumatism, unspecified

8.4

247.0

466

283

ZXD05

NOMESCO Finland

Urgent procedure

1.8

245.9

5015

15360

WZA10, ,

SPAT

7.5

245.5

503

345

R74

ICPC

Upper respiratory infection acute

1.7

245.2

7945

27865

F10.09

ICD-10 Finland

Alcohol intoxication UNS

7.5

245.1

502

344

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.0

244.9

919

1195

SPAT1283

SPAT

Restricted health certificate

1.8

244.9

5029

15434

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

244.6

1831

3731

K02.1

ICD-10 Finland

Caries of dentine

1.7

243.8

13049

52166

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

243.8

5133

15875

ZX120

NOMESCO Finland

Intravenous

3.7

242.2

1012

1431

R4120

NOMESCO Finland

Occupational therapy

3.9

242.1

945

1268

R06AE07

ATC

cetirizine; oral

1.7

241.6

8818

31891

R05

ICPC

Cough

1.9

241.5

4220

12275

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

241.5

1540

2874

SPAT1284

SPAT

Extensive health certificate

5.5

241.3

638

598

I49.3

ICD-10 Finland

Ventricular premature depolarization

5.4

240.5

645

614

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

13.0

239.9

358

141

TFP20

NOMESCO Finland

Cardiodefibrillation

402.8

239.0

316

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

238.7

10543

40017

R50.9

ICD-10 Finland

Fever, unspecified

2.3

238.2

2336

5422

N03AF01

ATC

carbamazepine; oral, rectal

5.0

237.0

681

696

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

797.2

236.6

308

S06.0

ICD-10 Finland

Concussion

2.4

236.4

2020

4396

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.2

236.1

1243

2064

P27

ICPC

Fear of mental disorder

11.7

235.4

368

160

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

4.1

235.2

856

1085

SPAT1252

SPAT

Overall medication plan or its review

5.4

235.1

632

603

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.3

234.2

2417

5736

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

234.0

299

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

39.1

233.9

254

A10BD07

ATC

metformin and sitagliptin; systemic

785.8

233.4

304

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

233.2

298

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

+∞

233.2

298

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

232.8

4334

12856

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

232.6

2133

4798

K59.09

ICD-10 Finland

Constipation, unspecified

4.6

231.2

737

832

E66

ICD-10 Finland

Obesity

3.6

231.1

987

1418

UKC02

NOMESCO Finland

Cystoscopy

2.9

230.8

1425

2608

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.4

230.7

2114

4753

R00.2

ICD-10 Finland

Palpitations

3.0

229.8

1320

2314

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

25.3

229.7

273

J01MA02

ATC

ciprofloxacin; systemic

1.8

229.2

5320

16900

A04AA01

ATC

ondansetron; systemic, rectal

4.3

228.7

779

933

C08CA02

ATC

felodipine; oral

6.5

228.0

518

407

N05AL01

ATC

sulpiride; systemic

52.4

227.7

237

Z51.5

ICD-10 Finland

Palliative care

14.2

226.2

324

116

A10AA02, ,

ATC

1462.4

226.1

292

B18.2

ICD-10 Finland

Chronic viral hepatitis C

13.5

225.9

331

125

IHZ02, ,

SPAT

6.3

224.5

522

422

SPAT1241

SPAT

Extensive assessment of psychosocial situation

9.8

223.6

385

201

F50.9

ICD-10 Finland

Eating disorder, unspecified

13.0

223.2

333

131

J01MA12

ATC

levofloxacin; systemic

2.4

222.8

2035

4565

F41

ICD-10 Finland

Other anxiety disorders

6.9

222.6

486

363

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

222.5

2837

7337

A10AA01, ,

ATC

1431.5

221.4

286

C03AA03

ATC

hydrochlorothiazide; oral

6.9

221.2

482

359

K78

ICPC

Atrial fibrillation/flutter

35.4

220.8

244

Z08

ICPC

Social welfare problem

21.5

220.7

274

IHZ04, ,

SPAT

10.7

220.4

361

172

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

24.8

220.2

263

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

8.7

219.1

405

238

R07.3

ICD-10 Finland

Other chest pain

2.8

218.1

1400

2618

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

216.6

3901

11414

N05AF01

ATC

flupentixol; systemic

44.9

216.4

230

E10

ICD-10 Finland

Type 1 diabetes mellitus

482.0

215.9

284

P25

ICPC

Phase of life problem adult

3.3

215.2

1056

1672

SPAT1238

SPAT

Brief therapy

6.4

214.7

495

396

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

49.7

214.7

225

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

6.6

214.6

483

375

R03BB04

ATC

tiotropium bromide; inhalant

3.7

213.9

877

1221

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

+∞

213.6

273

M01AB05

ATC

diclofenac; systemic, rectal

1.6

213.2

11820

46910

N06AX18

ATC

reboxetine; oral

72.4

213.0

214

HAC20

NOMESCO Finland

Total mastectomy

40.3

212.8

230

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.3

212.2

716

850

R60.0

ICD-10 Finland

Localized oedema

3.0

211.1

1226

2161

M04AA01

ATC

allopurinol; systemic

4.0

210.6

777

995

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

210.5

269

A10BB12

ATC

glimepiride; oral

468.3

209.6

276

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

63.6

209.3

213

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

27.4

208.6

243

L02

ICPC

Back symptom/complaint

2.3

208.1

2040

4719

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1343.9

208.1

269

201

Kela drug reimbursment

Chronic cardiac insufficiency

37.2

207.2

227

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

11.9

207.2

321

137

SPAT1153

SPAT

Removal of sutures

1.8

206.9

3967

11825

EBA15

NOMESCO Finland

Extraction of multiple teeth

6.6

206.6

465

361

A29

ICPC

General symptom/complaint other

2.5

206.0

1695

3611

C02AC05

ATC

moxonidine; oral

18.8

205.7

266

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

43.0

205.6

220

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

204.8

2267

5525

XF600

NOMESCO Finland

Bloodpressure measurement

4.0

204.6

764

988

A46

ICD-10 Finland

Erysipelas

2.6

204.3

1489

2982

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

1313.0

203.4

263

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

10.1

202.8

342

172

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

+∞

202.6

259

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

202.6

259

J02AC01

ATC

fluconazole; systemic

1.6

201.7

6953

24462

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

73.2

201.3

202

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

61.2

200.6

205

ZXA00

NOMESCO Finland

Right side

2.0

199.8

2883

7789

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.7

199.4

832

1173

SPAT1389

SPAT

Visit based on need for special support

3.6

199.3

850

1218

K80

ICPC

Cardiac arrhythmia NOS

3.7

199.2

834

1179

F60.8

ICD-10 Finland

Other specific personality disorders

68.0

198.9

201

F51

ICD-10 Finland

Nonorganic sleep disorders

3.2

198.8

1013

1643

EBA00

NOMESCO Finland

Extraction of tooth

1.6

198.5

7222

25732

SFA10

NOMESCO Finland

One-surface restoration

1.6

198.3

11488

45717

R01AD09

ATC

mometasone; nasal

1.6

198.2

8999

33831

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

49.8

196.6

206

F84.5

ICD-10 Finland

Asperger syndrome

18.2

196.5

257

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

267.2

196.1

263

J01DA01

ATC

[U] cefalexin

1.6

195.7

11063

43721

S97

ICPC

Chronic ulcer skin

5.9

195.3

482

418

SPAT1229

SPAT

Assessment of need for aid

4.5

195.2

638

736

A10BH05

ATC

linagliptin; oral

1256.4

194.8

252

R55

ICD-10 Finland

Syncope and collapse

2.8

194.7

1227

2267

SPAT1312

SPAT

General health counselling

1.7

194.4

6168

21197

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

433.9

194.0

256

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.8

194.0

1204

2205

I20.09

ICD-10 Finland

Unstable angina

220.8

193.0

261

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.6

191.7

1431

2899

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

191.5

1653

3600

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.8

191.1

1203

2221

E0000UV, ,

ATC

1.6

191.0

7592

27577

S29

ICPC

Skin symptom/complaint other

2.0

190.6

2888

7930

E87.6

ICD-10 Finland

Hypokalaemia

11.2

190.5

305

139

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.8

190.2

757

1029

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

165.3

190.0

261

HA1AA

NOMESCO Finland

X-ray mammography

4.7

189.7

580

629

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1220.4

189.3

245

N17

ICPC

Vertigo/dizziness

2.5

189.3

1573

3363

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

23.2

187.7

228

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

17.2

187.6

250

BAA60

NOMESCO Finland

Total thyroidectomy

41.0

187.4

202

PHD76

NOMESCO Finland

Resection of long saphenous vein

622.7

187.3

245

N07BA03

ATC

varenicline; oral

3.2

187.2

943

1517

A11

ICPC

Chest pain NOS

3.3

187.1

913

1438

IEV99

NOMESCO Finland

Other psychiatric network intervention

418.4

187.0

247

L12

ICPC

Hand/finger symptom/complaint

1.9

186.6

2950

8218

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.5

186.3

1519

3217

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

63.9

185.8

189

TFP34

NOMESCO Finland

Electrophysiological investigation

211.3

184.5

250

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.2

183.7

282

118

C07AG02

ATC

carvedilol; oral

10.6

182.7

301

145

WX780

NOMESCO Finland

Remote monitoring CPAP

4.0

182.4

673

861

X78

ICD-10 Finland

Intentional self-harm by sharp object

25.5

182.3

216

SPAT1281

SPAT

Other administrative function

2.7

180.9

1250

2429

I25.2

ICD-10 Finland

Old myocardial infarction

+∞

180.7

231

TKC20

NOMESCO Finland

Catheterisation of bladder

4.4

180.6

600

702

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.6

180.0

770

1105

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.9

179.8

1065

1896

SFA20

NOMESCO Finland

Two-surface restoration

1.5

179.8

12107

49350

K08.3

ICD-10 Finland

Retained dental root

3.1

179.5

987

1679

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.5

179.2

575

652

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

1153.7

179.2

232

Z72.2

ICD-10 Finland

Drug use

24.3

179.1

215

L01BC06

ATC

capecitabine; oral

89.2

178.3

176

T74.1

ICD-10 Finland

Physical abuse

4.8

178.3

538

576

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

243.5

178.3

240

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.6

177.7

459

419

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

176.9

3357

9920

A99

ICPC

Disease/condition unspecnature/site

2.6

176.8

1274

2531

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

18.3

176.3

230

R52.9

ICD-10 Finland

Pain, unspecified

2.4

176.0

1511

3278

WF002

NOMESCO Finland

Radical radiotherapy

14.3

175.9

251

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.3

175.6

598

715

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

175.5

4943

16383

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

153.8

174.6

241

M70.6

ICD-10 Finland

Trochanteric bursitis

2.5

174.6

1382

2881

N17.9

ICD-10 Finland

Acute renal failure, unspecified

10.8

174.3

284

134

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

174.0

988

1714

IER01

NOMESCO Finland

Psychoeducation, group

199.3

173.6

236

XKD00

NOMESCO Finland

Uroflowmetry

2.7

173.5

1173

2251

R96

ICPC

Asthma

2.5

173.0

1391

2922

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

172.8

1386

2908

J01FA06

ATC

roxithromycin; oral

1.6

172.2

6071

21291

F22.0

ICD-10 Finland

Delusional disorder

291.8

172.1

230

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

172.0

220

ZXA05

NOMESCO Finland

Left side

1.9

171.7

2625

7211

N03AF02

ATC

oxcarbazepine; oral

4.4

171.6

561

647

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

13.7

170.5

248

OAB38, ,

SPAT

3.7

170.1

701

978

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.9

170.0

499

520

JHB00

NOMESCO Finland

Hemorrhoidectomy

10.1

169.7

287

145

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.6

169.7

1202

2365

WF003

NOMESCO Finland

Adjuvant radiotherapy

37.5

169.2

185

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1108

1362

4.26

316.98

3.7

2.6

76.65

65.83

ng/l

2.25

1004

1234

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17898

76431

2.09

315.84

4.2

2.6

2.86

3.06

mmol/l

161.93

16862

72885

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

821

698

6.11

307.65

11.2

6.6

24.23

24.28

mmol/l

0.14

799

683

(1001926) Buprenorphine [Presence] in Urine by Screen method

2309

3462

3.64

307.65

2.9

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

9482

31499

1.92

307.65

3.4

2.3

0.00

estimate

0.46

2050

5611

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1487

1229

6.46

307.65

9.4

5.4

125.99

128.64

g/l

2.86

1452

1184

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16368

58263

2.76

307.65

4.9

2.1

37.98

35.33

mmol/mol

215.51

15403

55335

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1657

2203

4.02

307.65

3.8

2.3

223.69

217.49

u/l

1.16

1563

2088

(3021589) Normoblasts [#/volume] in Blood

9084

25350

2.39

307.65

9.1

5.3

0.00

e9/l

1.44

7439

21155

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3129

4688

3.76

307.65

3.3

1.4

245.55

33.31

ng/l

7.32

1809

1994

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17013

47529

4.93

307.65

4.3

2.0

14.37

14.23

pmol/l

10.40

15844

43380

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1651

1669

5.31

307.65

4.2

2.2

5.91

5.90

kpa

0.14

1596

1622

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1814

2056

4.75

307.65

2.5

2.4

0.23

0.24

g/l

2.57

1683

1946

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1013

672

7.91

307.65

1.5

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4203

11047

2.14

307.65

2.3

1.5

—

(3026008) Bacteria identified in Urine by Culture

4999

12527

2.31

307.65

2.6

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

2666

5304

2.74

307.65

2.9

1.3

—

(3016502) Oxygen saturation in Arterial blood

1584

1308

6.50

307.65

9.0

5.2

95.84

96.52

2.02

1538

1246

(3027945) Reticulocytes/100 erythrocytes in Blood

1569

2079

4.02

307.65

2.9

2.0

1.77

1.42

27.07

1394

1862

(3002582) Erythrocytes [#/volume] in Urine

5517

12548

2.63

307.65

3.0

2.0

67.84

66.11

e6/l

0.03

4178

9013

(3044640) Blood type and Crossmatch panel - Blood

5500

15281

2.09

307.65

2.3

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2401

2435

5.46

307.65

6.0

3.5

1.05

1.04

mmol/l

1.29

2255

2258

(3021601) Nitrite [Presence] in Urine by Test strip

9459

31560

1.91

307.65

4.5

3.3

0.00

estimate

1.10

2044

5529

(3021960) Folate [Moles/volume] in Serum or Plasma

4314

5708

4.51

307.65

1.5

1.2

19.70

21.29

nmol/l

7.11

3853

4935

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4057

6266

3.78

307.65

1.6

1.3

36232720.15

48912495.76

pmol/l

0.51

3530

5561

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

18849

60946

5.71

307.65

5.2

2.3

1.91

2.29

mu/l

1.38

17913

56897

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1827

2591

3.78

307.65

1.8

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5183

8598

3.68

307.65

2.1

1.4

1.49

1.16

157.19

4652

8044

(3019225) pH of Specimen

1686

2690

3.34

307.65

3.4

2.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1235

1230

5.30

307.65

7.4

4.7

24.73

24.83

mmol/l

0.34

1221

1225

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

823

730

5.85

307.65

11.4

5.8

—

(3002032) Base excess in Venous blood by calculation

1641

1652

5.33

307.65

4.2

2.2

1.82

2.01

mmol/l

1.07

1378

1411

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4890

12201

2.32

307.65

1.6

1.4

1.55

1.24

mmol/l

60.97

4209

10895

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2719

3452

4.39

307.65

2.3

1.6

2.47

2.53

g/l

4.30

2510

3222

(3037467) Urinalysis macro (dipstick) panel - Urine

13004

44081

2.23

307.65

4.0

2.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2818

6151

2.50

307.65

2.7

1.9

3.21

3.29

e6/l

0.13

1405

3157

(3013650) Neutrophils [#/volume] in Blood by Automated count

11800

30987

3.04

307.65

10.1

4.8

4.06

3.87

e9/l

13.88

10416

27429

(3013707) Erythrocyte sedimentation rate by Westergren method

14483

45051

2.91

307.65

3.8

2.9

8.98

7.33

mm/h

57.05

13541

42232

(3013826) Glucose [Moles/volume] in Serum or Plasma

10764

24564

3.42

307.65

4.9

2.3

6.42

5.86

mmol/l

116.49

9997

21037

(3028707) Methadone [Presence] in Urine by Screen method

1740

496

19.11

307.65

3.3

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

6460

9944

4.25

307.65

2.8

1.5

2.35

mmol/l

0.09

5877

8878

(3019309) Folate [Moles/volume] in Red Blood Cells

3262

3468

5.40

307.65

1.7

1.4

1165.86

1140.24

nmol/l

0.62

2561

2570

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1015

955

5.56

307.65

4.4

2.3

24.17

24.49

mmol/l

2.17

999

950

(36304419) Bacteria [Presence] in Urine

5075

11423

2.62

307.65

2.9

2.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8139

12375

4.73

307.65

5.6

2.7

1.21

1.22

mmol/l

16.50

7482

11135

(3024561) Albumin [Mass/volume] in Serum or Plasma

7876

13913

3.92

307.65

4.6

3.1

37.07

38.01

g/l

34.13

7346

12890

(3016879) Cocaine [Presence] in Urine

2568

4724

2.97

307.65

2.9

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2974

4081

4.09

307.65

2.3

1.6

14.55

21.59

umol/l

0.81

2765

3857

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1183

1308

4.75

307.65

3.3

2.4

5.19

5.14

kpa

1.21

1138

1243

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2487

3434

3.99

307.65

2.2

1.5

29.46

28.65

8.79

2404

3318

(3023183) Ammonium ion [Moles/volume] in Plasma

521

239

11.21

307.65

3.1

2.9

36.41

33.97

umol/l

0.50

485

221

(3023520) Reticulocytes [#/volume] in Blood

1106

1225

4.73

307.65

2.7

1.8

75.14

66.11

e9/l

8.24

800

902

(3003396) Base excess in Arterial blood by calculation

1770

1579

6.05

307.65

8.5

4.7

0.96

0.84

mmol/l

0.45

1420

1145

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6240

11826

3.33

307.65

3.1

1.4

74.26

10.54

ng/l

1.11

3145

3734

(3004119) Hemoglobin [Mass/volume] in Venous blood

998

964

5.41

307.65

3.6

1.8

134.76

141.64

g/l

12.98

974

949

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4972

8538

3.51

307.65

2.2

1.8

2.77

2.41

mg/l

22.83

4298

7317

(3007164) IgA [Mass/volume] in Serum or Plasma

5240

12802

2.40

307.65

1.5

1.3

2.22

2.14

g/l

3.08

3327

8705

(3027801) Oxygen [Partial pressure] in Arterial blood

1782

1576

6.11

307.65

8.4

4.8

12.44

14.41

kpa

19.01

1712

1496

(3009261) Glucose [Presence] in Urine by Test strip

9517

31876

1.90

307.65

3.4

2.4

0.01

0.00

estimate

1.57

1981

5477

(3009343) pH of Capillary blood

1174

1296

4.76

307.65

3.3

2.4

7.41

7.42

1.74

170

103

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3023

6424

2.59

307.65

2.5

1.8

1.02

0.86

e6/l

1.40

1601

3409

(3031040) Bacteria [#/volume] in Urine by Automated count

12312

39923

2.30

307.65

4.2

2.7

1144.24

1200.48

e6/l

0.04

152

413

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8937

14321

4.67

307.65

6.2

2.9

1.21

1.22

mmol/l

23.10

7558

12361

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1685

1797

5.03

307.65

3.2

2.9

4.55

4.82

pmol/l

12.92

1504

1652

(3027008) Opiates [Presence] in Urine

2673

5392

2.71

307.65

2.8

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3209

3047

6.05

307.65

2.8

1.3

815.08

156.25

ng/l

13.71

2509

2145

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2697

4472

3.33

307.65

1.9

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

682

208

16.99

307.65

5.7

2.9

372.22

389.66

umol/l

0.83

602

176

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14643

38104

3.96

307.65

7.1

3.9

74.90

70.62

u/l

29.32

13859

35636

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

20083

83104

4.59

307.65

10.1

4.6

29.06

25.98

u/l

59.32

19553

80249

(3002030) Lymphocytes/100 leukocytes in Blood

10084

28341

2.49

307.65

6.4

4.6

29.73

31.04

28.68

9534

27008

(3000850) Epithelial cells [#/volume] in Urine

3881

8141

2.71

307.65

2.5

1.8

6.93

6.48

e6/l

0.85

3470

7086

(3008152) Bicarbonate [Moles/volume] in Arterial blood

975

856

5.95

307.65

7.6

4.1

24.56

24.36

mmol/l

0.67

933

801

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2961

2928

5.74

307.65

3.5

1.9

0.82

0.86

mmol/l

22.96

2796

2744

(40758558) Short blood count panel - Blood

5182

11307

2.72

307.65

7.2

4.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8679

20006

2.99

307.65

2.4

1.9

70.59

75.11

nmol/l

35.38

8059

18813

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9702

19566

3.73

307.65

5.7

2.5

10.13

11.08

umol/l

9.36

9082

18256

(3006315) Basophils [#/volume] in Blood

10467

27690

2.77

307.65

6.3

4.8

0.04

e9/l

2.53

9201

24882

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3071

4585

3.76

307.65

2.4

1.5

2.42

2.40

mmol/l

8.84

2685

3914

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

535

100

27.56

307.65

2.2

3.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1440

1269

6.04

307.65

7.9

3.3

7.34

6.02

mmol/l

11.01

1384

1206

(3022096) Basophils/100 leukocytes in Blood

9382

25238

2.55

307.65

6.4

4.9

0.67

0.69

3.09

8790

23788

(3023368) Bacteria identified in Blood by Culture

4347

7352

3.48

307.65

4.5

2.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1493

1701

4.67

307.65

3.7

1.7

1.23

mmol/l

0.99

1267

1423

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4635

9767

2.77

307.65

1.9

1.4

0.88

0.78

mg/l

1.59

3288

6910

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2047

3742

2.94

307.65

1.2

1.1

136.88

93.68

iu/ml

3.51

751

1348

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8377

27311

1.89

307.65

2.5

2.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15014

54350

2.31

307.65

3.7

2.0

44.80

30.69

u/l

77.48

14295

52390

(40760892) CBC W Ordered Manual Differential panel - Blood

9932

25847

2.74

307.65

6.6

5.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17873

66613

3.14

307.65

4.0

2.2

5.77

5.35

mmol/l

293.64

16682

62579

(3018010) Neutrophils/100 leukocytes in Blood

9959

27945

2.48

307.65

6.2

4.5

55.98

55.13

10.62

9401

26652

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

19160

75796

3.63

307.65

13.0

5.1

19.41

21.17

mg/l

9.73

15101

52081

(3019198) Lymphocytes [#/volume] in Blood

10805

29393

2.72

307.65

6.4

4.6

2.02

1.97

e9/l

4.47

9737

26954

(3019060) Gas panel - Arterial blood

988

824

6.27

307.65

5.2

3.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2396

4239

3.07

307.65

2.6

1.9

6.87

6.22

umol/l

0.68

2002

3651

(3024354) Oxygen [Partial pressure] in Venous blood

1386

1436

5.12

307.65

3.6

2.1

4.94

4.77

kpa

1.24

1336

1398

(3002385) Erythrocyte distribution width [Ratio]

17075

68202

2.29

307.65

15.9

5.8

14.26

14.50

0.69

16796

66531

(3006504) Eosinophils/100 leukocytes in Blood

9686

26340

2.55

307.65

6.4

4.8

2.77

2.91

6.24

9113

24934

(3027944) Amphetamines [Presence] in Urine

2599

5380

2.63

307.65

2.8

1.3

—

(3044889) 12 lead EKG panel

12798

33840

3.25

307.65

3.2

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2067

3492

3.19

307.65

2.7

1.8

59.48

50.32

u/l

0.15

1765

3041

(3013115) Eosinophils [#/volume] in Blood

10790

28995

2.76

307.65

6.8

4.7

0.19

e9/l

0.71

9641

26319

(3026782) Osmolality of Urine

3651

7472

2.76

307.65

2.6

1.9

536.02

581.98

mosm/kgh2o

18.05

3148

6236

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7863

16255

3.27

307.65

3.4

2.1

33.18

28.59

u/l

1.55

7440

15613

(3001604) Monocytes [#/volume] in Blood

10440

27659

2.76

307.65

6.3

4.8

0.56

0.53

e9/l

24.12

9195

24879

(3030467) Casts [#/volume] in Urine by Automated count

5086

11045

2.73

307.65

2.9

2.0

0.29

0.24

e6/l

1.35

3803

7772

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1817

3036

3.20

307.65

3.2

1.7

—

(3018095) Leukocytes [#/volume] in Urine

6557

16942

2.36

307.65

3.5

2.3

57.25

62.86

e6/l

0.29

4483

10267

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2473

3041

4.49

307.65

2.4

1.6

23.97

27.35

15.77

2138

2654

(40768797) Stomach Pathology biopsy report

2746

5386

2.79

307.65

1.2

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2558

2525

5.65

307.65

2.0

1.6

371.52

383.46

nmol/l

1.65

2342

2368

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1114

1051

5.57

307.65

2.4

1.2

6.72

3.13

ug/l

3.75

975

905

(3014111) Lactate [Moles/volume] in Serum or Plasma

1594

1502

5.68

307.65

7.6

4.1

1.39

1.32

mmol/l

1.24

1551

1468

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5502

8635

3.97

307.65

2.3

1.5

236.28

214.60

u/l

0.33

5222

8173

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2199

4251

2.78

307.65

5.6

2.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1872

2667

3.77

307.65

1.8

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7628

12711

4.14

307.65

1.8

1.3

98.05

100.23

pmol/l

2.83

4277

6571

(3033658) Prothrombin time (PT) actual/Normal

4801

9497

2.99

307.65

4.0

2.2

95.92

97.10

2.53

4663

9219

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

17696

65317

3.11

307.65

10.7

3.9

95.41

93.32

ml/min/173m2

30.74

14488

50384

(40761511) CBC panel - Blood by Automated count

19883

84436

3.65

307.65

12.1

4.6

—

(3018418) pH of Serum or Plasma

5390

7592

4.44

307.65

3.6

1.9

7.40

0.00

1112

1132

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1145

1255

4.79

307.65

3.2

2.4

1.41

1.22

mmol/l

0.81

853

877

(3019069) Monocytes/100 leukocytes in Blood

9737

26536

2.55

307.65

6.7

4.9

8.16

8.13

0.36

9170

25183

(3007853) Bacteria identified in Skin by Aerobe culture

2514

5175

2.63

307.65

1.8

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

5831

7183

5.24

307.65

3.5

1.8

8.43

9.02

mmol/l

7.37

5111

6526

(3020682) Albumin/Creatinine [Ratio] in Urine

4212

4850

5.19

307.65

4.0

2.1

10.39

12.41

mg/mmol

1.05

2783

2724

(3028300) Cannabinoids [Presence] in Urine

2680

5399

2.71

307.65

2.9

1.3

—

(3015736) pH of Urine

8183

24674

2.08

307.65

3.1

2.2

5.95

0.05

766

3377

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6453

13066

3.12

307.65

2.8

1.7

54.70

59.55

u/l

4.94

5914

12166

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10574

29397

2.60

307.65

3.0

2.2

90.33

69.27

ug/l

23.52

9952

28098

(3019550) Sodium [Moles/volume] in Serum or Plasma

19252

66208

5.67

307.65

13.2

3.8

139.58

139.81

mmol/l

35.92

18770

63535

(3013512) EKG study

4559

8427

3.19

307.65

3.1

1.6

—

(3012516) Albumin [Mass/volume] in Urine

4064

4616

5.23

307.65

3.4

1.9

407.11

763.50

mg/l

2.17

2691

2521

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6086

15217

2.41

307.65

1.4

1.2

1.39

1.93

u/ml

2.42

1706

4572

(3019150) Specific gravity of Urine by Refractometry

4629

12626

2.08

307.65

3.5

2.4

1.02

1.01

kg/l

2.27

543

2146

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

942

836

5.88

307.65

2.6

1.3

108.36

34.36

ng/l

10.22

808

717

(3011288) Drugs identified in Urine by Screen method

2212

2432

4.99

307.65

3.9

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

19296

66672

5.70

307.65

13.3

3.8

3.92

3.93

mmol/l

5.37

18770

63739

(3022217) INR in Platelet poor plasma by Coagulation assay

7098

12364

3.82

307.65

8.4

2.0

1.10

1.03

inr

15.33

2438

4061

(3042936) Bacteria identified in Isolate by Culture

2584

5184

2.71

307.65

2.2

1.5

—

(3000991) Gas panel - Venous blood

1524

1429

5.70

307.65

9.2

4.8

—

(3036180) Methadone [Presence] in Urine

474

106

22.97

307.65

2.8

3.3

—

(3037522) Nuclear Ab [Titer] in Serum

3311

7560

2.42

307.65

1.4

1.3

473.39

578.09

titre

1.84

551

1384

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1783

1577

6.11

307.65

8.4

4.8

5.14

4.96

kpa

7.55

1711

1496

(3005719) IgG [Mass/volume] in Serum or Plasma

1784

3163

3.00

307.42

2.3

2.2

10.23

10.92

g/l

11.22

1639

2908

(3020891) Body temperature

690

552

6.46

299.82

5.1

2.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

20831

96153

4.58

298.02

20.2

6.9

41.24

41.93

1.73

19921

91166

(3020630) Protein [Mass/volume] in Serum or Plasma

1076

1369

4.11

295.20

2.0

1.3

67.23

68.81

g/l

7.37

1012

1279

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

383

105

18.65

295.14

3.7

2.0

0.32

0.29

u/ml

0.39

205

(3007461) Platelets [#/volume] in Blood

20845

96349

4.62

294.09

20.2

6.9

262.38

256.01

e9/l

39.58

20493

93405

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

17750

76140

2.02

292.82

3.9

2.5

4.70

4.97

mmol/l

239.45

16816

73076

(3018405) Lactate [Moles/volume] in Arterial blood

600

419

7.38

289.24

4.3

2.8

1.39

1.35

mmol/l

0.28

594

414

(3048689) Calprotectin [Mass/mass] in Stool

3543

9109

2.15

288.21

2.5

3.0

99.42

125.23

ug/g

4.38

2778

7449

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

430

174

12.66

284.68

2.8

2.3

0.93

0.80

nmol/l

1.22

355

160

(3035941) MCH [Entitic mass]

20852

96617

4.55

284.25

20.1

6.9

30.11

30.06

5.00

20657

95144

(3026493) Urate [Moles/volume] in Serum or Plasma

4236

11735

2.02

283.70

2.3

1.6

2564.35

3500.54

umol/l

1.03

3785

10858

(3024731) MCV [Entitic volume]

20852

96633

4.55

283.51

20.1

6.9

89.96

89.60

26.43

20656

95148

(3026361) Erythrocytes [#/volume] in Blood

20856

96666

4.57

283.46

20.2

6.9

4.61

4.65

e12/l

27.14

20465

93548

(3010813) Leukocytes [#/volume] in Blood

20857

96712

4.55

281.70

20.2

6.9

6.79

6.44

e9/l

111.40

20460

93551

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2296

4913

2.51

280.37

2.5

1.8

12.71

14.04

nmol/l

10.00

2088

4697

(3000963) Hemoglobin [Mass/volume] in Blood

20858

96778

4.53

279.02

20.3

6.9

138.01

139.35

g/l

35.82

20656

95310

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

17615

75721

1.97

278.64

3.9

2.5

1.39

1.52

mmol/l

270.89

16629

72713

(4035726) Immunohistochemistry procedure

1106

1516

3.81

276.28

1.4

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

669

574

6.02

274.05

2.6

2.0

432.11

447.56

ug/l

0.04

620

511

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1298

2022

3.37

272.13

1.8

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

5240

15839

1.88

271.85

3.7

2.5

0.00

estimate

0.05

1981

5444

(3017143) Hepatitis C virus Ab [Presence] in Serum

3936

10763

2.03

271.63

1.8

1.6

—

(3010421) pH of Blood

601

461

6.71

269.86

3.7

2.0

7.41

0.05

540

437

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

908

1082

4.36

268.60

1.7

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3842

10455

2.03

268.24

1.3

1.2

21.03

29.38

iu/ml

1.83

1118

3561

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

360

109

16.87

268.09

3.2

2.3

41482.02

43372.48

ug/l

0.47

360

109

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1075

1487

3.77

265.21

3.7

1.9

18.03

2.22

ug/l

2.13

828

971

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7489

25443

1.74

264.10

3.3

2.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16969

72522

1.86

260.27

3.5

2.4

1.39

1.17

mmol/l

193.75

15948

69526

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

342

103

16.95

255.15

2.2

1.9

160.73

81.55

ug/min

0.84

223

(3022313) Gas panel - Capillary blood

834

997

4.34

245.57

3.4

2.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1366

2352

3.05

245.20

1.8

1.6

1.24

1.26

g/l

0.12

1274

2202

(3027315) Oxygen [Partial pressure] in Blood

529

391

6.95

244.31

3.7

1.9

9.11

9.31

kpa

1.05

516

386

(3013290) Carbon dioxide [Partial pressure] in Blood

527

391

6.92

242.68

3.7

1.9

5.01

4.97

kpa

0.37

514

386

(3012501) Base excess in Blood by calculation

527

391

6.92

242.68

3.7

1.9

2.17

1.72

mmol/l

2.64

335

224

(3004588) Protein electrophoresis panel - Serum or Plasma

844

1030

4.25

242.63

1.8

1.3

—

(1616796) Gas panel - Central venous blood

503

358

7.21

238.94

3.1

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4341

12813

1.88

237.32

3.3

2.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3566

9838

1.99

236.82

1.3

1.2

6.50

11.17

u/ml

4.20

1424

4368

(3027273) Bicarbonate [Moles/volume] in Venous blood

708

753

4.85

236.62

3.6

2.0

25.22

25.49

mmol/l

1.01

684

721

(3017181) Myelocytes/100 leukocytes in Blood

1682

3371

2.64

231.39

4.4

3.8

0.87

0.45

6.81

512

590

(3024928) Oxygen saturation in Venous blood

439

280

8.03

225.23

3.3

1.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

664

702

4.88

223.19

3.9

2.0

54.01

47.85

4.70

655

696

(36660697) Celiac disease serology panel - Serum

2250

5281

2.28

222.92

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

405

241

8.59

217.41

1.1

18617.63

8.48

iu/ml

0.50

119

(3002179) Metamyelocytes/100 leukocytes in Blood

1567

3149

2.62

213.92

4.1

3.6

0.60

0.42

1.21

450

547

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

531

466

5.85

213.01

2.1

1.5

1.57

1.58

ug/l

0.01

480

400

(3000570) Elastase.pancreatic [Mass/mass] in Stool

612

632

4.98

210.62

1.4

1.2

301.90

346.96

ug/g

3.41

310

315

(3020191) Ethanol [Moles/volume] in Serum or Plasma

412

272

7.75

206.42

1.6

1.2

1.45

1.64

promille

0.83

311

214

(3021440) Promyelocytes/100 leukocytes in Blood

1599

3308

2.55

206.12

4.5

3.9

0.09

0.03

3.47

429

527

(40768804) Tissue Pathology biopsy report

6941

24336

1.64

204.83

1.9

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

448

338

6.78

203.55

2.3

1.4

17.18

18.83

7.95

216

133

(3021387) Prolactin [Units/volume] in Serum or Plasma

1725

3740

2.43

202.12

1.6

1.4

328.31

268.20

mu/l

5.78

1542

3432

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

746

956

4.03

201.97

3.4

2.6

24.65

24.68

mmol/l

0.10

713

912

(3036489) Thrombin time

801

1098

3.77

199.21

2.2

1.6

20.96

20.31

2.28

677

898

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

621

687

4.65

198.89

1.9

1.8

1.44

1.09

g/l

12.60

543

597

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1101

1906

3.01

194.96

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

247

18.46

189.97

2.8

1.4

170.77

107.07

umol/l

0.76

121

(3025159) Blasts/100 leukocytes in Blood

1529

3221

2.49

189.61

4.5

3.9

0.11

0.02

1.04

352

458

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5274

17558

1.68

185.89

2.4

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5718

19584

1.64

179.79

2.5

2.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

695

931

3.85

177.87

2.3

1.7

95.89

93.04

1.90

663

872

(3007930) Methemoglobin/Hemoglobin.total in Blood

557

632

4.52

173.44

6.1

2.7

0.92

0.93

0.17

519

589

(3009214) Lutropin [Units/volume] in Serum or Plasma

1294

2623

2.58

172.71

1.5

1.3

8.05

7.59

u/l

0.69

1045

2215

(3022145) Colonoscopy Study observation

2120

5380

2.09

171.70

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

889

1462

3.15

170.45

2.1

1.7

198.11

208.80

pmol/l

1.57

846

1424

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

560

652

4.41

169.44

6.1

2.6

1.94

1.62

3.94

520

605

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

735

1066

3.55

169.28

1.3

1.2

444.20

424.00

mg/l

0.56

687

1019

(40761535) Cells panel - Urine sediment

1390

2952

2.46

168.99

3.2

2.4

—

(40761536) Microorganisms panel - Urine sediment

1952

4844

2.13

167.04

3.6

2.3

—

(3000494) Fungus identified in Specimen by Culture

2291

6077

2.00

164.76

1.5

1.3

—

(3003181) Sodium [Moles/volume] in Urine

280

143

9.96

164.61

1.6

1.4

62.88

78.57

mmol/l

2.20

224

121

(3041096) Erythrocytes [Presence] in Urine by Automated

5565

19290

1.61

163.94

2.9

2.0

—

(3008295) Osmolality of Serum or Plasma

268

130

10.48

162.06

1.7

1.6

284.30

284.85

mosm/kgh2o

0.10

213

109

(3021901) Oxygen saturation in Capillary blood

324

220

7.50

159.12

2.4

1.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

656

942

3.58

153.04

1.4

1.2

7190.98

596.65

e6/l

0.60

517

773

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

655

943

3.57

152.27

1.4

1.1

14.64

10.79

e6/l

0.61

484

750

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

638

902

3.63

152.00

2.6

2.0

171.51

151.66

5.46

604

838

(3028626) Oxygen [Partial pressure] in Capillary blood

476

542

4.49

147.57

3.2

8.84

9.37

kpa

5.46

460

527

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1217

2588

2.45

147.05

2.0

1.6

36.58

42.00

nmol/l

9.06

1185

2567

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1100

2229

2.56

146.39

1.1

2.74

6.55

u/ml

0.39

(46235355) HIV 1 and 2 tests - Meaningful Use set

6830

25431

1.51

143.10

2.2

1.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

989

1926

2.66

141.89

1.2

1.00

0.70

u/ml

0.34

122

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1369

3131

2.28

141.25

2.4

1.5

79.58

84.72

ml/min/173m2

3.58

517

872

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

631

934

3.47

141.09

1.2

1.1

3.67

3.46

mmol/l

6.34

590

879

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

228

109

10.62

138.95

6.8

4.6

9.95

8.88

mg/l

1.49

210

(3035637) Corticotropin [Mass/volume] in Plasma

318

252

6.42

138.92

1.6

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

424

475

4.56

133.79

1.7

1.2

—

(3047181) Lactate [Moles/volume] in Blood

521

698

3.82

133.12

6.5

2.6

1.28

1.16

mmol/l

2.18

453

611

(3044290) Cell count panel - Cerebral spinal fluid

600

897

3.43

132.25

1.4

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

426

494

4.40

129.39

1.6

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

743

1300

2.94

128.58

1.8

1.21

1.12

g/l

11.33

715

1245

(3009445) Proteinase 3 Ab [Units/volume] in Serum

794

1446

2.83

128.36

1.6

1.7

8.49

11.60

u/ml

0.52

(4200892) Spirometry reversibility

1361

3236

2.19

127.99

1.4

1.3

—

(3002256) Pathology report gross observation

2082

5809

1.89

127.83

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

570

846

3.45

126.90

2.6

1.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

720

1250

2.96

126.19

1.8

0.24

0.22

g/l

7.03

690

1194

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

430

523

4.20

123.65

1.3

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2360

6927

1.80

123.52

1.5

—

(1002224) Polysomnography panel

1305

3104

2.19

122.47

1.1

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

710

1246

2.93

122.20

1.2

1.4

77.14

120.17

titre

0.47

115

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

326

313

5.30

120.35

2.9

1.6

32.63

22.27

mg/l

3.01

255

257

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

317

297

5.43

119.76

2.8

1.5

1.25

1.16

ratio

0.51

(4146454) Self-monitoring of blood glucose

144

23.50

119.11

2.4

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

325

316

5.23

118.55

2.9

1.6

40.21

26.22

mg/l

3.59

254

259

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1632

4290

1.99

118.44

2.3

2.2

21.06

20.81

au/ml

0.04

132

570

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1388

3432

2.10

118.32

2.0

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

282

235

6.10

118.20

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

686

1203

2.93

118.19

1.2

1.3

562.35

1332.11

titre

1.60

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

634

1067

3.05

116.82

2.7

1.9

3.58

3.59

g/l

0.09

603

1005

(3039000) Anion gap in Blood

330

333

5.04

116.08

8.2

3.7

11.58

11.48

mmol/l

0.14

296

290

(3023511) Choriogonadotropin [Units/volume] in Urine

1124

2567

2.27

115.80

1.5

1.2

—

(3011985) Renin [Units/volume] in Plasma

265

210

6.41

115.79

1.8

1.6

63.17

36.93

mu/l

1.96

239

200

(3018572) Chloride [Moles/volume] in Blood

330

334

5.03

115.74

8.2

3.7

105.03

105.48

mmol/l

0.62

296

291

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

582

934

3.19

115.51

4.2

2.7

1.33

1.03

mg/l

17.06

550

884

(3023323) Follitropin [Units/volume] in Serum or Plasma

1689

4535

1.95

115.42

1.4

1.3

20.50

25.07

iu/l

6.56

1411

3989

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1518

3925

2.02

115.10

1.2

53.55

48.91

au/ml

0.22

246

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

462

633

3.73

114.63

1.8

1.2

3.66

3.59

g/l

0.49

446

590

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

523

785

3.41

114.56

1.9

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

462

634

3.72

114.39

1.8

1.2

7.20

6.89

g/l

2.76

446

591

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

462

635

3.72

114.16

1.8

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1475

3786

2.03

114.02

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

865

1764

2.53

113.24

1.9

2.0

39.90

41.22

u/l

1.00

798

1705

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

381

454

4.28

112.19

1.1

1.0

118.41

116.89

0.36

346

389

(3016650) Hepatitis A virus Ab [Presence] in Serum

550

873

3.22

110.97

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3386

11281

1.60

110.90

2.2

1.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

449

618

3.71

110.74

1.8

1.2

2.93

2.72

g/l

3.24

433

575

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

529

823

3.29

109.98

1.1

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

338

368

4.68

109.98

2.8

1.5

941.27

33408.47

u/ml

0.49

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

408

525

3.96

109.63

1.8

1.3

0.40

0.15

g/l

2.13

383

476

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

298

289

5.24

108.98

1.7

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

1719

4734

1.90

108.90

1.3

269.79

268.26

u/ml

0.01

1590

4411

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

397

504

4.02

108.46

1.3

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1949

5602

1.82

108.29

2.4

2.1

5849.53

6886.04

u/l

0.62

661

2632

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

397

505

4.01

108.20

1.3

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

147

16.17

108.16

2.1

2.7

15.28

21.63

umol/l

2.14

147

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

589

997

3.03

107.49

2.0

4.01

3.36

iu/l

1.06

237

418

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

426

580

3.75

106.57

1.9

1.2

10.05

10.21

g/l

0.28

409

536

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

245

197

6.31

105.81

1.4

1.2

398.83

314.77

pmol/l

1.42

209

177

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

433

603

3.66

105.15

5.7

2.2

681.40

814.34

iu/ml

0.13

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1661

4574

1.90

105.10

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

1474

3915

1.96

103.46

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5916

22541

1.44

102.38

1.8

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2756

8879

1.64

102.38

2.1

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1937

5656

1.79

102.01

3.7

2.5

30.10

32.10

11.45

1451

4131

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

377

485

3.96

101.34

1.7

1.2

0.02

0.00

g/l

0.59

365

461

(40760888) Immunoglobulin light chains.free panel - Serum

257

235

5.55

99.33

3.1

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

368

479

3.91

97.49

1.7

1.2

38.56

40.40

g/l

5.08

352

435

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

287

303

4.81

96.47

1.7

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

340

421

4.11

95.74

1.7

1.2

0.00

g/l

-0.00

330

402

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

638

1213

2.69

95.31

1.6

396.00

410.00

titre

0.03

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

264

260

5.16

95.15

1.2

1.3

0.27

0.11

nmol/l

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

341

426

4.07

95.01

1.7

1.2

0.00

g/l

0.50

330

403

(3020961) Endomysium IgA Ab [Titer] in Serum

1387

3716

1.94

94.73

1.1

83.16

200.69

titre

2.12

125

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

255

247

5.24

93.40

1.5

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

314

373

4.28

92.82

1.5

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

397

575

3.52

91.42

1.1

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

427

654

3.33

90.82

2.6

—

(3017732) Neutrophils [#/volume] in Blood

1471

4086

1.87

90.20

2.9

1.6

4.81

4.38

e9/l

0.58

1238

3580

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

262

271

4.91

89.95

1.2

1.3

0.53

0.50

nmol/l

0.60

251

260

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

386

555

3.54

89.79

1.3

1.2

3.35

3.36

u/ml

0.00

163

245

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

713

1481

2.47

89.77

1.9

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

319

397

4.09

89.30

1.6

1.5

—

(3003338) MCHC [Mass/volume]

16832

77450

1.44

89.28

16.9

5.8

333.98

334.35

g/l

5.47

16725

76607

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

582

1092

2.73

89.04

1.6

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

273

300

4.62

88.00

1.2

1.1

98.49

93.35

1.78

258

274

(1617658) Protocol used for examination of sentinel lymph nodes

43.15

87.97

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

129

72.49

87.89

2.7

2.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

395

590

3.41

87.12

1.2

4.01

3.52

u/ml

0.13

129

203

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

328

428

3.90

86.65

3.1

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

795

1768

2.31

86.58

2.2

2.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

559

1046

2.73

85.93

1.9

2.1

10.45

9.54

mg/l

1.09

531

1009

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

310

394

4.00

84.61

2.0

2.7

22.58

23.71

nmol/l

0.72

291

388

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

236

234

5.12

84.54

1.2

1.3

—

(3011648) Oxygen content in Venous blood

170

114

7.55

84.33

2.4

2.1

11.48

12.69

1.78

170

114

(3037121) Protein [Mass/volume] in Urine

605

1194

2.59

84.23

3.3

2.9

0.29

0.30

g/l

0.02

285

475

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

217

198

5.56

84.08

1.9

1.5

2020118.58

368883.13

iu/ml

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

299

381

3.99

81.36

1.7

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

299

382

3.98

81.10

1.7

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

381

584

3.32

80.96

3.1

2.9

577.86

18.90

u/ml

0.80

309

500

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

925

2272

2.09

79.54

1.6

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

558

1098

2.60

78.12

1.4

1.2

19.40

19.31

u/l

0.02

462

932

(3003327) Ova and parasites identified in Stool by Light microscopy

1002

2570

2.01

76.90

1.8

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

214

215

5.04

75.71

1.5

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

642

1378

2.38

75.44

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

707

1590

2.28

75.01

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

712

1610

2.27

74.62

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

18.64

74.28

6.4

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

716

1627

2.25

74.20

1.2

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

258

316

4.14

73.66

1.5

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

198

189

5.31

73.62

1.6

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

401

678

3.01

73.30

2.0

1.9

134.89

137.34

g/l

1.13

306

512

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

258

318

4.12

73.12

1.4

1.2

48.10

14.02

u/l

1.63

222

278

(3037756) Immunofixation for Serum or Plasma

204

203

5.09

72.87

1.7

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

609

1298

2.40

72.62

1.3

1.2

241.01

221.37

u/ml

1.00

373

814

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5207

20362

1.38

72.57

1.8

1.7

—

(3000012) Reticulocyte production index

170

141

6.10

71.66

2.1

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

201

202

5.04

71.11

3.8

1.2

67.08

219.16

u/ml

0.90

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

276

371

3.78

70.27

1.6

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

251

315

4.04

69.63

3.0

2.0

1.29

1.50

0.29

230

278

(3006653) Thiamine [Moles/volume] in Blood

148

107

7.00

69.58

1.5

1.2

137.22

131.49

nmol/l

0.58

148

107

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

627

1383

2.32

69.44

1.5

1.4

0.39

0.53

nmol/l

1.76

485

1188

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

493

967

2.60

69.44

1.5

1.4

10.33

10.97

iu/ml

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

234

278

4.27

69.25

1.5

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

628

1402

2.29

67.71

1.2

1.3

36.09

31.47

u/ml

0.15

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3780

14153

1.42

67.09

3.3

2.6

1.45

1.61

ug/l

3.88

3390

13298

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

312

478

3.32

66.40

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

342

559

3.11

66.00

1.1

1.0

—

70.07

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1671

5264

1.65

65.98

1.6

1.2

—

(3016038) Potassium [Moles/volume] in Urine

120

8.66

65.35

1.5

1.4

34.34

35.80

mmol/l

0.15

109

(3048929) Epstein Barr virus Ab [Presence] in Serum

1143

3245

1.81

64.94

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

126

7.86

64.42

1.6

1.4

35.47

42.54

g/l

4.01

113

(3016018) Differential panel - Cerebral spinal fluid

304

472

3.27

63.45

1.4

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

190

203

4.74

63.20

1.7

1.3

—

(21494755) Public health laboratory ask at order entry panel

2448

17183

0.68

62.97

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

255

354

3.65

62.29

3.7

35.36

26.51

mu/l

2.06

237

331

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

244

328

3.77

62.17

1.1

289.81

279.11

mg/l

0.85

220

304

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

212

257

4.18

61.34

3.7

2.8

1205.05

13.97

u/ml

0.54

202

236

(3008898) HLA-B27 [Presence]

1154

3358

1.77

60.41

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

529

1151

2.34

60.36

1.4

1.2

24.27

21.85

u/ml

0.11

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

220

280

3.98

60.06

1.7

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

346

605

2.91

59.89

1.1

1.46

1.38

g/l

2.69

314

556

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

207

251

4.18

59.88

1.6

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

133

102

6.59

59.81

1.7

1.4

2.68

1.43

nmol/l

0.66

100

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

265

390

3.45

59.78

2.3

2.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

799

2068

1.98

59.66

2.6

1.7

0.18

0.22

e6/l

0.88

764

1984

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

317

527

3.05

59.60

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

12.09

59.45

3.4

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

528

1156

2.33

59.43

1.4

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2543

9023

1.47

59.27

1.8

2.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

113

8.04

58.70

1.5

1.3

92.03

85.23

nmol/24h

0.29

113

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

58.56

8.0

0.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

220

286

3.90

58.51

1.5

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

220

287

3.88

58.26

1.5

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

601

1406

2.18

58.15

1.8

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

438

888

2.51

57.87

1.4

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

515

1132

2.32

57.47

1.2

1.3

35.11

42.44

u/ml

0.34

100

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

654

1592

2.10

57.40

2.0

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

10.10

57.25

1.2

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

566

1300

2.22

57.19

1.2

1.3

10.14

13.19

u/ml

0.35

202

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

108

8.26

57.14

1.5

1.2

13.21

13.80

pmol/l

0.55

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

223

299

3.78

57.04

1.3

1.1

1.88

1.69

mmol/l

1.80

209

283

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

470

996

2.40

56.74

3.5

3.4

57.04

55.70

1.65

470

996

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

263

400

3.33

56.63

1.1

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

394

765

2.62

56.61

1.5

1.7

0.65

0.78

g/l

1.74

293

606

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

181

205

4.47

56.60

1.6

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

109

7.98

56.35

2.3

1.5

22.75

14.91

umol/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

234

331

3.58

55.79

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

134

113

5.99

55.78

1.6

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

463

984

2.40

55.56

3.3

3.4

4.05

3.72

e9/l

2.73

463

984

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

557

1288

2.21

55.40

1.2

1.3

3.25

10.68

u/ml

1.56

134

(3003694) ABO and Rh group [Type] in Blood

5868

24132

1.31

55.34

1.6

1.7

—

(3023410) Appearance of Cerebral spinal fluid

288

476

3.07

54.68

1.5

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1031

2989

1.77

54.54

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

147

141

5.27

54.51

3.1

1.6

37.61

63.03

mg/l

0.53

103

(40768795) Lymph node Pathology biopsy report

135

119

5.73

54.09

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

492

1096

2.29

53.31

1.4

1.2

101.70

106.19

u/ml

0.31

229

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

302

524

2.92

53.00

1.2

1.1

35.87

41.43

mg/l

1.21

242

432

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

352

670

2.67

52.52

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

748

1983

1.93

52.16

1.2

1.3

—

(3042733) HLA Ab [Presence] in Serum

14.35

52.14

4.5

2.9

—

(3012441) Differential panel - Pleural fluid

105

7.36

51.40

1.6

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

435

937

2.36

50.75

1.2

9.03

22.29

u/ml

—

(3011412) CD3 cells [#/volume] in Blood

238

365

3.30

50.68

2.5

2.2

1.31

1.32

e9/l

0.04

206

313

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

330

619

2.71

50.59

1.2

257.50

103.33

titre

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

267

444

3.05

50.24

1.4

1.3

6.42

6.74

g/l

0.65

185

317

(4062490) Immunoglobulin typing, IgG

267

445

3.04

50.06

1.4

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

144

148

4.92

49.94

1.6

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

144

148

4.92

49.94

1.6

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

144

148

4.92

49.94

1.6

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

266

443

3.04

49.94

1.4

1.3

0.38

0.41

g/l

0.60

181

319

(3028192) IgG subclass 2 [Mass/volume] in Serum

266

444

3.04

49.76

1.4

1.3

2.91

3.20

g/l

1.61

183

316

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

289

511

2.87

49.16

1.1

1.0

230.14

224.02

mg/l

0.21

246

454

(4094501) Cardiovascular stress test using bicycle ergometer

427

930

2.33

48.65

1.1

1.0

—

(40768793) Breast Pathology biopsy report

312

580

2.73

48.63

1.3

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

440

975

2.30

48.27

1.2

1.3

4.82

7.40

u/ml

0.22

(3004451) EKG impression Narrative

16.98

48.05

1.4

1.0

—

(40768806) Pleura Pathology biopsy report

7.27

47.59

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

7.14

47.42

1.6

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

281

500

2.85

47.31

1.1

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

187

254

3.73

47.12

2.1

2.0

—

(3023419) Bacteria identified in Sputum by Culture

213

319

3.38

46.98

2.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

211

314

3.40

46.96

8.3

1.6

7.27

5.74

mmol/l

6.59

180

242

(3023199) Leukocytes [#/volume] in Pleural fluid

107

6.36

46.87

1.6

1.3

3244.96

5690.43

e6/l

1.22

(3049717) Cytology report of Urine Cyto stain

373

778

2.44

46.59

2.1

2.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

228

360

3.21

46.53

1.2

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

252

425

3.00

46.39

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.97

46.12

1.6

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

163

202

4.08

46.06

1.2

1.1

—

(3045716) Anion gap in Serum or Plasma

7.12

45.94

2.2

1.7

9.81

9.75

mmol/l

0.04

(3024932) HLA-DR beta [Type]

12.70

45.50

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

6.42

45.49

1.6

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

169

218

3.92

45.49

1.1

—

(3024471) HLA-A [Type]

12.00

44.98

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

162

204

4.02

44.92

3.0

2.1

54.03

54.38

0.07

142

174

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

7.48

44.14

1.5

1.3

430.09

671.62

u/l

1.43

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

150

180

4.21

44.05

2.6

50.07

51.98

umol/l

0.28

132

173

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

128

133

4.86

43.95

1.0

260.51

336.51

ng/l

1.83

105

(3017569) Oxygen content in Arterial blood

9.25

43.76

3.5

1.5

—

(40768443) Skin Pathology biopsy report

746

2094

1.82

43.76

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

103

6.12

43.75

2.1

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

127

132

4.86

43.60

1.0

39.76

46.73

ng/l

0.66

102

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

6.64

43.56

1.3

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

495

1206

2.09

43.37

2.3

2.0

6.75

7.05

titre

0.03

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

437

1018

2.18

42.76

1.9

1.8

4916.67

3354.07

titre

0.26

(3019977) pH of Arterial blood

7.13

42.63

4.2

2.0

7.44

0.19

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

126

133

4.79

42.59

1.0

811.26

701.98

ng/l

1.27

100

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

146

177

4.17

42.38

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

154

196

3.97

42.18

1.6

6.12

5.13

u/l

0.74

133

177

(40768446) Kidney Pathology biopsy report

6.39

41.86

1.5

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

6.41

41.51

1.5

1.3

104512.45

60210.53

e6/l

0.30

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

163

221

3.73

41.23

1.2

1.1

72.93

92.25

1.49

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

924

2812

1.68

41.12

2.4

1.6

39.24

23.94

u/ml

2.15

890

2719

(3008757) Leukocyte morphology finding [Identifier] in Blood

166

230

3.65

40.82

3.2

1.8

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

162

221

3.71

40.66

2.5

1.9

99.59

102.39

0.39

153

198

(3002079) Sodium [Moles/time] in 24 hour Urine

107

101

5.35

40.39

1.3

176.50

147.88

mmol/24h

1.63

107

101

(3013005) Retinol [Moles/volume] in Serum or Plasma

142

176

4.08

40.18

1.8

1.9

1.92

1.85

umol/l

0.48

134

168

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

796

2340

1.74

40.07

1.1

3.35

6.48

u/ml

2.21

113

427

(3045788) Cell count panel - Pleural fluid

6.51

39.80

1.6

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

39.72

39.77

1.1

—

(3007463) Buprenorphine [Presence] in Urine

59.49

39.56

4.9

4.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

9.05

39.31

2.0

1.1

213.50

4.45

ug/min

1.18

(3042631) Mycobacterium sp identified in Specimen

166

237

3.54

39.22

2.3

3.0

—

(3045142) Bone marrow Pathology biopsy report

123

138

4.50

39.01

1.3

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

139

176

3.99

38.36

2.7

2.5

1.58

1.42

g/24h

0.22

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

245

456

2.72

38.21

1.3

1.2

6.00

6.28

umol/l

0.49

225

429

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2047

13725

0.72

37.95

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

242

451

2.72

37.66

1.5

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

241

451

2.71

37.23

1.5

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

208

358

2.94

37.14

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

111

119

4.71

36.98

1.4

1.2

5.92

5.09

mmol/l

2.11

101

109

(3025468) Yersinia sp identified in Specimen by Organism specific culture

240

451

2.69

36.80

1.5

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

242

458

2.68

36.63

1.5

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

15729

74370

1.24

36.50

3.9

3.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

247

475

2.63

36.30

1.5

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1144

3790

1.55

36.11

1.6

1.3

4.17

3.16

mg/l

3.19

894

2213

(3024522) Salmonella sp identified in Specimen by Organism specific culture

242

462

2.65

36.05

1.5

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

169

3.94

35.96

1.1

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

5.46

35.83

1.9

1.3

—

(3045414) Leukocytes [Presence] in Urine

785

2377

1.69

35.56

1.7

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

299

647

2.34

34.68

1.9

2.0

5.35

5.73

mmol/24h

1.00

269

610

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

146

208

3.55

34.66

1.1

0.91

6.03

nmol/l

0.89

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

134

179

3.78

34.63

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

299

648

2.34

34.56

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

700

2073

1.72

34.35

1.2

—

(3000492) Spirometry study

2140

8071

1.37

34.30

1.4

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

106

117

4.57

34.27

1.2

1.1

17.50

6.38

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

193

334

2.92

34.19

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

13.71

33.94

1.8

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

11.91

33.83

2.3

1.7

522.23

1564.15

e6/l

0.50

(3039162) Centromere protein B Ab [Units/volume] in Serum

287

617

2.36

33.77

1.2

1.3

59.68

21.43

u/ml

0.94

(3026389) Candida sp identified in Specimen by Organism specific culture

332

769

2.19

33.03

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

189

330

2.90

33.01

1.1

—

(4034850) Laboratory test

614

1772

1.76

32.92

9.8

3.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

139

199

3.53

32.80

2.8

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

156

243

3.24

32.64

1.2

65.13

63.00

u/l

0.11

137

221

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

178

302

2.98

32.61

2.7

2.3

526.52

498.89

e6/l

0.31

143

245

(3024891) Influenza virus A+B Ag [Presence] in Specimen

664

1970

1.72

32.38

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

194

348

2.82

32.37

1.1

0.99

1.01

u/l

0.14

134

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

7.45

32.22

2.9

2.5

—

(40768441) Liver Pathology biopsy report

140

206

3.43

31.82

1.5

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

10.71

31.49

1.1

1.4

84.83

35.93

ng/l

0.37

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

178

311

2.89

31.09

1.3

1.4

73.68

72.18

0.72

167

297

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

172

295

2.95

30.98

2.8

2.2

0.22

0.23

e9/l

0.27

142

244

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

588

1710

1.75

30.74

1.6

1.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

175

305

2.90

30.70

1.3

1.4

455.28

514.17

mu/l

0.33

164

291

(3020717) Zinc [Moles/volume] in Serum or Plasma

154

248

3.14

30.67

1.6

1.5

22.15

25.08

umol/l

0.51

145

243

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

212

413

2.60

30.49

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.94

30.37

2.8

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

211

412

2.59

30.22

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

167

286

2.95

30.17

1.1

1.2

1.06

1.05

ratio

0.39

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

226

459

2.49

29.97

1.3

1.5

—

titre

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

16.79

29.94

5.2

4.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1403

9630

0.71

29.52

1.4

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

745

2338

1.62

29.47

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

8.15

29.01

1.7

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

11.33

28.61

1.9

1.5

1764.41

20331.50

e6/l

—

(3017704) Immunofixation for Urine

6.45

28.54

1.7

1.5

—

(3035880) pH of Pleural fluid

7.92

28.47

1.4

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

120

172

3.52

28.34

1.8

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

122

177

3.48

28.34

2.3

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.91

27.76

3.3

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.91

27.76

3.3

2.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

4.70

27.75

21.6

12.0

122.84

120.26

ug/l

0.09

(3033923) Metanephrine [Moles/time] in 24 hour Urine

8.69

27.47

1.1

0.68

0.73

umol/24h

0.19

(3004716) Salmonella sp identified in Stool by Organism specific culture

1435

5252

1.40

27.29

1.3

1.5

—

(21494434) Karyotype in Bone marrow

109

4.21

26.96

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

109

4.21

26.96

2.6

2.9

26.92

27.01

umol/l

0.02

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

4.21

26.96

1.4

1.1

—

(3044007) Cell count panel - Peritoneal fluid

12.59

26.72

1.7

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

138

227

3.07

26.66

4.2

5.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.04

26.56

1.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

26.53

1.8

0.0

27.34

—

nmol/l

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

188

372

2.55

26.31

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

188

372

2.55

26.31

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

5.64

26.31

1.6

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

5.64

26.31

1.6

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

122

187

3.29

26.24

1.0

1.1

95.87

93.10

0.43

136

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

188

373

2.55

26.18

1.1

—

(3044927) Protein electrophoresis panel - Urine

100

133

3.79

26.11

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

185

366

2.55

25.91

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

185

367

2.55

25.78

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

185

367

2.55

25.78

1.1

—

(3033799) Differential panel - Peritoneal fluid

10.87

25.54

1.8

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2863

11691

1.27

25.51

3.1

2.6

21.28

22.48

2.71

891

3915

(3017315) Amylase [Enzymatic activity/volume] in Urine

126

203

3.13

25.17

1.3

1.1

459.50

367.62

u/l

0.23

115

195

(3051593) INR in Capillary blood by Coagulation assay

13.94

25.12

7.7

1.0

—

(3000330) Specific gravity of Urine by Test strip

631

1985

1.62

24.76

2.7

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

175

345

2.56

24.70

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

119

187

3.21

24.70

1.6

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

167

322

2.62

24.59

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1789

11535

0.76

24.41

1.4

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

136

235

2.92

24.31

1.1

1.2

23.25

6.15

u/ml

0.39

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

108

4.02

24.14

1.4

1.1

—

(3006270) Folate [Moles/volume] in Blood

158

299

2.67

24.10

1.1

414.64

400.71

nmol/l

0.34

149

287

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

717

2349

1.55

23.75

1.6

0.30

0.49

iu/ml

0.27

123

448

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

3.81

23.71

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

112

174

3.25

23.67

1.2

1.1

4.38

3.38

iu/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.15

23.07

2.0

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

4.18

23.00

2.3

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

127

218

2.94

22.98

2.7

2.9

45.86

42.81

0.88

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.11

22.80

2.0

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

10.07

22.76

1.9

1.1

7.73

1323081.00

nmol/l

1.02

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.43

22.64

1.4

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.43

22.64

1.4

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.25

22.52

2.7

2.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

10.35

22.49

1.1

1.2

46.32

34.38

mg/l

—

(3022621) pH of Urine by Test strip

1046

3746

1.42

22.43

2.5

2.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

8.60

22.43

1.7

1.2

10.77

10.88

g/l

0.01

(43055514) Macroprolactin [Presence] in Serum or Plasma

134

242

2.79

22.27

1.3

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

433

1272

1.73

21.97

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

450

1337

1.71

21.94

1.1

10.41

12.24

au/ml

0.25

117

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.46

21.89

1.9

—

(40768800) Prostate Pathology biopsy report

133

242

2.77

21.82

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

757

5495

0.68

21.74

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

375

1060

1.79

21.67

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

325

883

1.86

21.27

1.1

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

21.07

1.4

0.0

588.75

—

nmol/l

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

180

390

2.33

21.03

1.2

1.3

183.64

257.27

titre

0.51

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

180

390

2.33

21.03

1.2

1.3

102.50

333.85

titre

—

(3000060) B lymphocytes [#/volume] in Blood

141

3.36

20.96

2.0

2.1

216.67

142.76

e6/l

1.38

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

6.92

20.80

1.1

1.2

353.90

310.20

pmol/l

0.24

(3034426) Prothrombin time (PT)

3.94

20.63

1.3

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

101

161

3.16

20.60

1.1

96.00

96.37

0.04

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

121

216

2.83

20.55

1.1

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

162

338

2.42

20.52

1.3

1.6

6.41

8.23

ug/l

0.53

140

301

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.00

20.47

1.1

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.54

20.39

2.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.54

20.39

2.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

102

165

3.12

20.35

1.2

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

105

3.74

20.15

1.5

1.3

17.35

15.55

umol/l

2.21

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

103

169

3.07

20.10

1.6

2.0

144.17

113.75

3.54

162

(3004616) Nuclear Ab [Presence] in Serum

222

537

2.09

20.07

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.02

20.04

1.5

1.2

35611.36

2701.00

u/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

144

287

2.53

20.01

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.60

19.89

1.3

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

101

165

3.09

19.85

1.2

116.56

111.81

0.43

147

(21494814) CD8 cells/100 lymphocytes in Specimen

126

3.44

19.85

2.1

1.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

125

233

2.71

19.70

1.6

2.0

128.04

107.63

2.84

120

224

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

7.55

19.62

2.4

4.9

1.05

1.10

mmol/l

0.03

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.90

19.61

1.1

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

8.81

19.44

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

119

3.47

19.19

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

7.27

19.12

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

4.39

19.08

1.1

1.0

81.88

78.58

ug/l

0.23

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

6.16

18.99

2.3

3.8

43.76

29.88

mg/l

0.16

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

157

3.08

18.86

1.1

98.70

99.23

0.04

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

126

3.36

18.78

1.1

1.2

96.87

70.44

u/l

1.25

108

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.94

18.75

1.1

85.44

97.57

0.35

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.13

18.71

2.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.97

18.67

1.1

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

7.88

18.65

4.5

4.1

38.70

35.36

ug/min

0.05

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1137

4266

1.36

18.53

1.3

227.43

235.39

miu/ml

0.30

538

2263

(3051611) Lipemic interference index of Serum or Plasma

131

259

2.55

18.53

2.8

1.9

—

(3035320) C reactive protein [Mass/volume] in Body fluid

162

356

2.30

18.42

2.6

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

191

452

2.13

18.28

1.2

1.3

2.35

3.37

u/ml

0.49

253

(3029075) Extractable nuclear Ab panel - Serum

126

3.32

18.25

1.1

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.85

18.25

1.2

1.1

71.75

94.19

0.73

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

121

3.37

18.23

1.1

1.2

32.45

11.48

u/l

1.24

103

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

515

1664

1.57

18.20

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

167

2.96

18.06

1.2

1.3

—

(3044941) Cell count panel - Synovial fluid

238

617

1.95

17.95

1.4

1.3

—

(3022689) Creatine [Moles/volume] in Urine

5.53

17.73

1.4

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

110

203

2.73

17.70

1.3

1.2

0.29

g/l

0.33

162

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

127

3.25

17.53

1.3

75.56

147.69

titre

—

(3000475) Leukocytes [#/volume] in Synovial fluid

328

951

1.75

17.52

1.7

1.6

13819.90

10835.44

e6/l

0.41

230

711

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

162

2.96

17.50

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

139

292

2.40

17.44

1.4

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.54

17.38

1.3

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

385

3056

0.63

17.14

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

393

1208

1.65

17.01

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

102

3.51

16.90

1.1

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

7.05

16.80

2.3

1.2

7.07

5.58

mmol/l

0.70

(3050129) First trimester maternal screen panel - Serum or Plasma

1183

7678

0.76

16.66

1.4

—

(3051651) Icteric interference index of Serum or Plasma

129

3.16

16.64

3.5

2.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

104

3.44

16.47

1.1

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.71

16.41

1.5

1.2

146.94

139.14

nmol/l

0.07

(3017509) Phencyclidine [Presence] in Urine

3.61

16.38

2.6

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

407

1279

1.61

16.18

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

151

2.94

16.08

1.4

1.5

4.56

6.09

u/l

0.68

131

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

124

3.17

16.08

1.1

1.2

79.87

66.48

u/l

1.11

116

(3014051) Protein [Presence] in Urine by Test strip

419

1329

1.60

16.05

2.2

1.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

114

3.27

15.99

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3877

17036

1.18

15.85

1.5

—

(44813793) Dust mix specific IgE antibody measurement

205

528

1.96

15.81

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

7.32

15.79

1.5

1.3

22.17

20.61

g/l

0.10

(1761482) Bacteria [#/volume] in Urine by Culture

261

732

1.80

15.62

3.4

2.2

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

+∞

15.61

1.7

0.0

402.80

—

nmol/l

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

100

189

2.67

15.48

1.3

1.2

109.90

107.42

0.37

167

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

727

2609

1.41

15.47

1.1

2.91

2.77

u/ml

0.10

375

1354

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

442

1437

1.56

15.28

1.4

157.50

45.11

pmol/l

1.92

429

1396

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

123

3.11

15.27

1.1

1.2

17.99

9.97

u/l

1.58

113

(3047007) Chlamydophila sp Ab [Presence] in Serum

392

1240

1.60

15.21

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

171

2.74

15.14

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

7.68

14.80

1.1

1.70

1.27

umol/24h

1.33

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

871

5802

0.74

14.77

1.5

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

5.31

14.50

1.3

1.8

253.76

54.38

mu/l

0.62

(3021788) Differential panel - Synovial fluid

273

795

1.74

14.46

1.6

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.06

14.40

1.4

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

159

386

2.08

14.40

1.7

1.5

30.28

41.27

2.77

258

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

168

2.70

14.29

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

176

446

1.99

14.25

1.8

1.5

21.81

27.98

mg/l

0.73

113

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

180

2.63

14.24

1.1

77.78

293.20

ng/l

0.71

(3023420) DNA double strand Ab [Units/volume] in Serum

234

654

1.81

14.21

1.6

19.60

26.77

iu/ml

0.79

(3022493) Free Hemoglobin [Mass/volume] in Plasma

121

3.04

14.16

5.8

1.2

68.47

13924.37

mg/l

1.61

(3038026) Centromere Ab [Units/volume] in Serum

139

322

2.18

14.13

1.2

29.58

19.73

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

654

2353

1.41

13.76

1.1

6.84

7.25

u/ml

0.20

354

1347

(3013727) Leukocytes other/100 leukocytes in Blood

4.34

13.71

3.0

1.5

51.85

52.90

0.09

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.34

13.65

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

7.05

13.47

1.1

1.2

51.26

133.53

ug/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

411

1355

1.54

13.42

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

624

2238

1.41

13.38

1.1

1.63

1.21

u/ml

0.49

281

1033

(3014271) Vancomycin [Susceptibility]

4.01

13.37

2.7

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

665

4536

0.73

13.23

1.4

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

124

2.93

13.16

1.3

1.7

7.98

8.26

ug/l

0.27

124

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.99

13.02

1.7

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

5.78

12.77

1.2

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

3.62

12.76

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

161

2.63

12.76

1.3

1.4

16.92

20.46

u/ml

0.27

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

130

307

2.14

12.68

1.2

2.00

8.54

u/ml

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

205

573

1.81

12.51

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

133

319

2.10

12.49

1.2

54.80

30.51

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

635

2315

1.39

12.42

1.1

2.58

2.81

u/ml

0.19

333

1161

(3032057) Clostridioides difficile [Presence] in Stool

4.77

12.41

2.1

1.7

—

(3002619) Bacteria identified in Specimen by Culture

3.52

12.31

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

4.13

12.10

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.13

12.10

1.1

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

179

2.48

11.95

1.1

1.0

—

(3001556) Androgen free Index in Serum or Plasma

124

2.80

11.79

1.3

1.1

—

(3028433) Virus identified in Specimen by Culture

122

2.81

11.66

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

300

954

1.59

11.52

1.4

1.3

209.90

203.59

pmol/l

0.08

300

954

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

186

2.41

11.46

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4023

18111

1.14

11.45

1.8

1.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

139

2.65

11.28

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.95

11.22

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.31

11.14

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

192

548

1.77

11.01

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

13.84

11.00

1.9

1.1

—

(3048879) Bone marrow aspiration report

5.95

11.00

2.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.03

10.93

3.4

4.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

199

576

1.74

10.90

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1017

6377

0.79

10.79

1.4

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

191

550

1.75

10.65

1.7

1.6

63.01

47.86

5.16

113

388

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

943

5956

0.79

10.65

1.4

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.87

10.60

2.6

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

293

946

1.56

10.60

2.5

2.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

942

5941

0.79

10.51

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

101

233

2.18

10.50

1.2

1.3

—

(3045424) Erythrocytes [Presence] in Urine

283

909

1.57

10.47

1.5

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

948

5970

0.79

10.45

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

948

5965

0.79

10.37

1.4

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

542

1990

1.38

10.24

1.1

5.44

5.21

u/ml

0.06

273

1001

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

111

270

2.07

10.16

2.0

1.3

26.89

802.63

ug/l

1.27

257

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.33

10.14

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.46

10.01

1.1

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

183

531

1.74

9.98

1.4

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

7.97

9.95

3.0

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

122

2.64

9.92

1.3

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

757

4859

0.78

9.78

1.4

1.5

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.53

9.78

1.1

—

(3005033) Fetal Nuchal fold Thickness US

755

4846

0.78

9.76

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

104

252

2.08

9.64

1.2

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

11.18

9.28

1.2

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

261

848

1.55

9.25

1.2

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.22

9.22

2.8

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

779

4941

0.78

9.15

1.4

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.03

9.14

1.4

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

907

3647

1.26

9.03

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

215

2.13

9.01

1.6

1.4

5.08

4.90

0.03

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

4.08

8.81

1.2

1.1

44.71

79.94

2.09

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

3.60

8.79

2.0

1.5

2.82

1.71

ug/l

0.88

(3020491) Glucose [Moles/volume] in Blood

157

455

1.74

8.67

1.8

1.3

6.22

5.23

mmol/l

3.93

124

365

(3024869) Neuronal Ab [Presence] in Serum

3.90

8.64

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2012

8782

1.17

8.61

2.3

2.1

0.58

0.67

ug/l

2.56

1086

3882

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

117

2.54

8.55

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.05

8.46

1.2

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.05

8.46

1.2

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.03

8.42

1.1

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

9.56

8.27

1.0

1.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

6.47

8.16

1.1

1.0

—

(4281824) Cell count and differential, peritoneal fluid

130

363

1.81

8.14

1.1

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

139

2.36

8.11

4.1

2.6

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

130

2.40

8.06

1.4

1.7

0.25

0.28

nmol/l

0.15

106

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.84

7.95

3.2

1.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.91

7.86

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

489

1847

1.34

7.83

1.1

8.90

5.61

u/ml

1.25

217

807

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

408

1498

1.38

7.83

1.0

1.1

2.83

3.07

u/ml

0.16

217

926

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

185

2.12

7.72

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.74

7.70

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

247

829

1.50

7.65

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

431

1604

1.36

7.62

1.1

1.0

0.85

0.49

u/ml

0.40

121

362

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

145

2.26

7.44

2.8

1.4

169.79

112.59

ng/l

0.48

105

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

152

2.22

7.38

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

115

320

1.81

7.33

1.2

1.1

9.43

13.11

u/ml

0.15

206

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

8.23

7.32

3.4

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

126

361

1.76

7.31

1.1

13.20

15.32

u/ml

0.16

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.84

7.13

1.3

1.1

119.07

35.04

mg/l

0.30

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.59

7.06

2.1

2.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.90

7.03

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

+∞

7.02

6.3

0.0

491.78

—

umol/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

234

1700

0.69

6.98

1.4

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.70

6.98

1.1

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

111

2.40

6.97

1.1

1.0

—

(3024263) Appearance of Synovial fluid

187

2.05

6.91

1.7

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

157

2.15

6.87

1.5

1.6

—

878.80

iu/ml

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

212

706

1.51

6.87

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

139

418

1.68

6.84

1.1

1.0

1529.31

1381.90

miu/ml

0.76

139

418

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

166

524

1.60

6.78

1.1

5.60

6.98

iu/ml

0.42

163

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

896

5415

0.82

6.76

2.1

1.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.63

6.69

2.1

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

5.35

6.61

2.8

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

9.43

6.60

1.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

532

0.47

6.57

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

3.21

6.53

1.8

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

2.61

6.50

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.61

6.50

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.61

6.50

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.61

6.50

1.2

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

250

1769

0.71

6.45

1.6

7.62

7.34

mmol/l

1.40

233

1694

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

249

1.86

6.45

1.6

1.5

2.59

3.44

u/field

0.30

179

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

7.13

6.43

1.1

1.0

30.89

22.71

u/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

126

2.24

6.34

1.5

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

8.38

6.25

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.37

6.24

1.1

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

171

557

1.55

6.17

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.39

6.15

1.5

1.3

40.09

52.21

1.13

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.82

6.04

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.53

5.98

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.52

5.96

1.0

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.86

5.62

1.5

2.7

31.73

47.27

umol/l

1.81

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.00

5.53

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

274

1.75

5.51

1.7

2.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

+∞

5.46

1.0

0.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.79

5.44

1.5

2.40

2.38

mg/l

0.00

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.26

5.39

1.2

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

122

380

1.62

5.36

1.4

56767.14

41584.33

e6/l

0.21

253

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.94

5.36

1.9

1.6

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

4.28

5.33

1.2

1.1

23.50

2.20

—

(4212803) Bone marrow aspirate examination

11.06

5.30

1.0

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

8.62

5.16

1.0

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.74

5.15

1.4

1.5

3.28

6.14

mg/l

1.11

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.74

5.15

1.4

1.5

3.56

3.84

mg/l

0.07

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.74

5.15

1.4

1.5

2.34

1.50

mg/l

0.34

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.74

5.15

1.4

1.5

2.48

4.56

mg/l

0.92

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.74

5.15

1.4

1.5

2.16

2.17

mg/l

0.00

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.74

5.15

1.4

1.5

2.12

1.67

mg/l

0.23

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.74

5.15

1.4

1.5

1.39

1.71

mg/l

0.15

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.74

5.15

1.4

1.5

0.94

1.13

mg/l

0.13

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.74

5.15

1.4

1.5

0.80

3.21

mg/l

1.70

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.59

5.12

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

148

489

1.53

5.10

1.2

—

(3019174) dRVVT (LA screen)

2.97

5.09

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.97

5.09

1.2

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.21

5.07

1.1

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.82

5.03

1.4

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.42

5.03

1.1

1.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.68

5.01

1.1

1.5

0.67

2.11

umol/24h

—

(3052592) Norovirus Ag [Presence] in Stool

3.10

5.01

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.60

4.99

1.3

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

212

760

1.41

4.86

1.5

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.71

4.72

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.30

4.69

1.2

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.19

4.62

1.1

43.60

20.36

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.90

4.58

1.9

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.72

4.56

1.0

9.41

10.17

u/l

0.06

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.30

4.55

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

6.71

4.54

1.4

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

135

1.98

4.54

2.1

2.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

188

1.79

4.34

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

123

407

1.52

4.28

1.0

15.77

14.48

u/ml

0.19

263

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

189

1.78

4.27

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

189

1.78

4.27

1.0

—

(3022475) Manganese [Moles/volume] in Blood

3.66

4.22

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

108

2.05

4.18

1.0

0.00

0.12

u/ml

0.56

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

100

318

1.58

4.14

1.8

1.6

2.41

2.14

u/field

0.18

156

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.47

4.03

1.2

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.18

4.01

3.5

4.6

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

4.40

3.92

1.1

16.33

6.00

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

+∞

3.90

5.8

0.0

0.91

—

g/l

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.17

3.86

1.7

1.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.67

3.85

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

487

2023

1.22

3.83

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.35

3.78

1.5

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.71

3.76

1.0

0.20

0.04

u/ml

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.71

3.76

1.3

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

486

2024

1.21

3.74

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.57

3.74

1.6

1.4

94.20

76.30

ng/l

0.36

(3016031) Almond IgE Ab [Units/volume] in Serum

2.18

3.69

1.0

0.88

0.83

u/ml

0.02

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.21

3.66

1.0

1.1

32.81

16.89

u/ml

0.42

(3035933) Granulocytes/100 leukocytes in Blood

257

1.61

3.65

1.5

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

496

2076

1.21

3.64

2.0

2.4

4.83

5.38

umol/l

0.60

355

1538

(3050794) Legionella sp Ab [Presence] in Serum

3.05

3.53

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

5.03

3.52

1.2

1.1

0.17

0.00

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

134

1.84

3.51

1.0

0.28

0.24

u/ml

0.10

(3041918) Cholesterol [Moles/volume] in Pleural fluid

4.09

3.46

1.6

1.3

1.68

2.76

mmol/l

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.47

3.45

3.4

3.9

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

212

808

1.32

3.45

1.1

1.0

4.22

2.10

u/ml

0.41

194

(3039443) Prostate specific Ag panel - Serum or Plasma

289

1820

0.80

3.44

1.4

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

524

2221

1.19

3.38

1.3

1.2

3.39

3.56

ug/l

0.23

490

2129

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

107

364

1.48

3.36

8.3

6.7

493.19

9277.88

u/ml

0.58

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.95

3.36

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.52

3.32

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

201

767

1.32

3.27

1.0

0.90

1.00

u/ml

0.07

171

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

109

1.89

3.22

1.5

1.4

28.88

43.65

1.66

(3020874) Milk IgE Ab [Units/volume] in Serum

207

796

1.31

3.20

1.1

4.56

4.79

u/ml

0.02

244

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

5.66

3.19

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.65

3.17

1.2

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.26

3.16

1.3

1.5

0.43

0.42

ug/l

0.04

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

115

403

1.44

3.14

1.8

2.0

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

2.87

3.05

1.0

11.38

11.61

u/ml

0.01

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.58

3.03

1.1

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.77

3.02

1.0

0.22

0.01

u/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.31

2.97

1.0

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

3.95

2.93

1.1

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

113

1.83

2.92

1.5

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

5.75

2.91

14.8

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

5.75

2.91

2.1

1.7

59.65

63.29

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.52

2.89

1.1

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.67

2.88

1.2

1.3

5.37

7.12

mmol/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

129

1.76

2.84

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

235

1.54

2.80

1.1

5.27

9.70

u/ml

0.37

167

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3233

15359

1.07

2.79

1.5

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.45

2.76

1.1

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.11

2.75

1.6

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.90

2.75

1.3

1.2

38.30

43.60

g/l

1.60

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

108

385

1.41

2.74

2.3

2.0

8.75

10.40

mg/l

1.91

318

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.04

2.73

1.1

1.2

25.71

15.44

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.04

2.73

1.1

1.2

29.00

29.69

u/ml

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

5.03

2.68

1.0

2.50

2.75

—

(3036071) Salmonella sp Ab [Titer] in Serum

299

1.46

2.68

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

218

869

1.26

2.63

1.7

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.97

2.63

1.1

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.97

2.63

1.2

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.46

2.60

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.17

2.50

1.2

1.3

13.64

13.21

nmol/l

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

312

1.44

2.50

1.9

1.7

95.78

124.50

au/ml

0.26

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

769

3441

1.13

2.50

1.5

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.59

2.49

4.0

4.6

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.59

2.49

1.0

1.1

921.30

241.00

u/l

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

222

1.52

2.48

1.1

1.79

6.31

u/ml

0.59

197

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.47

2.47

1.3

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

6.03

2.35

2.8

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

6.03

2.35

1.2

1.0

—

(40758292) HTLV I+II Ab panel - Serum

1.78

2.31

1.4

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.31

2.24

1.8

1.7

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.40

2.19

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

317

1.40

2.18

1.1

1.0

—

(3001729) Color of Synovial fluid

2.74

2.16

2.2

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.21

2.16

1.7

1.6

—

(3025577) Chromium [Mass/volume] in Blood

149

1.59

2.14

2.1

1.87

2.66

ug/l

0.72

131

(1761868) Lipid panel - Serum or Plasma

7133

34846

1.04

2.13

2.5

1.8

—

(3016135) IgD [Mass/volume] in Serum

3.66

2.12

1.5

1.2

91.50

70.84

mg/l

—

(3026470) Cobalt [Mass/volume] in Blood

154

1.57

2.09

2.1

2.23

2.81

ug/l

0.40

145

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

3.23

2.08

1.1

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

2.77

2.01

3.6

1.5

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

3.91

2.01

2.3

2.0

—

(3025130) Human papilloma virus identified in Specimen

358

1551

1.16

1.94

1.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

596

0.75

1.89

6.3

6.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

596

0.75

1.89

3.1

3.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.87

1.84

1.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.52

1.84

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.83

1.82

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.74

1.82

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

161

1.50

1.77

1.0

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.74

1.76

1.0

1.1

0.17

1.57

u/ml

0.59

(3015183) Erythrocyte sedimentation rate

138

551

1.26

1.76

1.3

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.72

1.75

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.41

1.75

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

119

468

1.28

1.72

2.5

3.0

196.67

113.17

au/ml

0.57

(3029396) Erythrocyte agglutination [Presence] in Blood

603

0.77

1.71

2.8

3.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

620

0.77

1.70

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.81

1.70

1.1

0.08

31.40

u/ml

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.87

1.69

1.1

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

1.63

1.66

1.0

0.36

1.87

u/ml

0.77

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.35

1.57

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

3.35

1.57

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

113

1.56

1.55

1.9

1.8

1.34

1.72

mg/l

0.99

(3051387) C reactive protein [Mass/volume] in Capillary blood

304

1329

1.15

1.53

3.2

2.3

20.98

26.46

mg/l

1.99

166

793

(3009871) Measles virus Ab [Titer] in Serum

222

1.38

1.52

1.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.24

1.52

1.2

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

127

1.51

1.47

1.0

1.1

0.07

1.75

u/ml

1.37

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

472

2635

0.90

1.45

2.0

1.8

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.71

1.44

1.1

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

136

1.48

1.43

1.0

1.1

0.58

0.74

u/ml

0.09

(3011841) English Walnut IgE Ab [Units/volume] in Serum

124

1.50

1.42

1.0

1.1

0.15

3.04

u/ml

1.82

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.59

1.40

6.3

2.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

137

1.47

1.39

1.0

1.1

8.82

5.74

u/ml

0.12

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

126

516

1.23

1.36

3.0

3.7

8.35

8.78

mg/l

0.31

423

(3007700) Barley IgE Ab [Units/volume] in Serum

1.70

1.27

1.1

1.12

23.32

u/ml

0.46

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.13

1.27

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.13

1.27

1.2

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.19

1.22

4.1

6.5

0.23

0.21

mmol/l

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

387

1.25

1.22

1.0

—

(40762814) Titanium [Mass/volume] in Blood

1.79

1.19

2.4

2.6

6.30

8.28

ug/l

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.50

1.16

1.0

1.1

9.88

9.43

u/ml

0.03

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

139

1.41

1.15

1.2

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.58

1.15

1.0

0.25

4.72

u/ml

1.33

(3034614) HLA Ag [Interpretation]

2.16

1.10

1.2

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

188

1.34

1.09

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

144

615

1.18

1.07

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.20

1.05

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

366

1.22

1.00

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.51

0.99

1.3

1.1

2.23

2.01

mmol/24h

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.55

0.94

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.78

0.85

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.64

0.82

1.3

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.81

0.79

1.0

1.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

133

1.32

0.77

1.0

1.55

0.50

u/ml

0.47

(3022670) pH of Venous cord blood

1.96

0.77

1.0

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.76

0.71

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

314

1458

1.08

0.68

1.4

1.5

6.88

6.15

mmol/l

4.36

286

1312

(3006598) pH of Arterial cord blood

1.68

0.67

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.49

0.67

1.0

1.1

3.62

1.84

u/ml

—

(3029612) Listeria sp Ab [Titer] in Serum

1.68

0.65

1.5

1.3

—

(3013762) Body weight Measured

1.63

0.65

1.3

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.45

0.64

2.2

1.8

0.76

0.75

u/field

0.02

(3027305) Fractional oxyhemoglobin in Arterial cord blood

1.89

0.61

1.0

1.1

32.37

29.23

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

140

631

1.12

0.58

2.2

1.5

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.68

0.57

1.0

1.1

65.15

62.66

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

129

584

1.11

0.52

1.2

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

138

1.24

0.51

1.4

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.69

0.51

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.60

0.48

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

131

597

1.10

0.48

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.38

0.44

1.8

1.2

310.36

296.88

umol/24h

0.13

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.43

0.0

2.3

—

(3008607) Semen analysis panel

160

1.19

0.43

1.3

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

102

1.23

0.38

5.7

3.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

103

1.22

0.36

5.7

3.1

22.45

23.90

mg/l

0.19

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

145

1.18

0.35

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.69

0.34

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

284

1.12

0.32

2.3

2.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.72

0.32

1.0

1.1

7.19

8.41

mmol/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

111

522

1.07

0.25

1.2

1.4

—

(3009677) Dengue virus Ab [Presence] in Serum

1.29

0.24

1.1

—

(3020650) Glucose [Presence] in Urine

223

1.10

0.23

1.7

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.18

0.19

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

191

998

0.96

0.19

1.4

1.3

30.14

34.44

nmol/l

1.09

165

951

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.15

0.18

1.1

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.14

0.18

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.87

0.14

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

121

1.08

0.09

2.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

107

0.94

0.05

1.1

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

114

576

0.99

0.00

1.4

1.5

5.55

4.96

mmol/l

6.00

103

554

(3003577) Lead [Moles/volume] in Blood

1.02

0.00

1.3

1.5

0.48

0.22

umol/l

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.90

-0.00

1.0

0.59

0.88

u/ml

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

1.01

-0.00

11.6

6.2

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint ANTIDEPRESSANTS and mortality.

Females

Parameter	HR [95% CI]	p-value
ANTIDEPRESSANTS	1.488 [1.39, 1.6]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.031

During the follow-up period (1.1.1998 — 31.12.2019), 103249 out of 611724 females with ANTIDEPRESSANTS died.

Males

Parameter	HR [95% CI]	p-value
ANTIDEPRESSANTS	1.798 [1.66, 1.95]	< 0.001
Birth year	0.981 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 79482 out of 387224 males with ANTIDEPRESSANTS died.

Mortality risk

Mortality risk for people of age

years, who have ANTIDEPRESSANTS.

N-year risk	Females	Males
1	0.079%	0.249%
5	0.594%	1.465%
10	1.431%	3.877%
15	2.817%	7.036%
20	5.127%	11.528%

Relationships between endpoints

↥

Index endpoint: ANTIDEPRESSANTS – Depression medications

GWS hits: 59

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Depression medications

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints